Page last updated: 2024-08-24

triazoles and Candidiasis

triazoles has been researched along with Candidiasis in 419 studies

Research

Studies (419)

Timeframe	Studies, this research(%)	All Research%
pre-1990	40 (9.55)	18.7374
1990's	45 (10.74)	18.2507
2000's	219 (52.27)	29.6817
2010's	109 (26.01)	24.3611
2020's	6 (1.43)	2.80

Authors

Authors	Studies
Abruzzo, GK; Apgar, JM; Balkovec, JM; Dragovic, J; Fan, W; Flattery, AM; Galgoci, AM; Giacobbe, RA; Gill, CJ; Greenlee, ML; Hsu, MJ; Kahn, JN; Kirwan, R; Lee, S; Liberator, P; Liu, H; Mamai, A; Meng, D; Misura, AS; Motyl, M; Nelson, K; Parker, DL; Peel, M; Powles, M; Racine, F; Sperbeck, D; Wildonger, KJ; Wilkening, RR	1
Bodai, L; Bohner, F; Gabaldón, T; Gácser, A; Kocsis, K; Nosanchuk, JD; Papp, C; Szekeres, A; Tóth, R; Vágvölgyi, C; Varga, M; Willis, JR	1
Bidaud, AL; Dannaoui, E; Schwarz, P	1
Abdelbary, AA; Elshafeey, AH; Moftah, NH; Mosallam, S; Ragaie, MH	1
Dong, J; Kan, S; Liang, G; Liu, W; Song, N; Zhang, M; Zheng, H	1
Butler-Laporte, G; Cheng, MP; Del Corpo, O; Demir, KK; Ekmekjian, T; Lee, TC; Sheppard, DC	1
McCarthy, MW; Walsh, TJ	1
Champleboux, M; Chauvel, M; Cornet, M; Courçon, M; d'Enfert, C; Ferri, E; Garnaud, C; Govin, J; Harbut, M; Hull, M; Kashemirov, BA; Maubon, D; McKenna, CE; Mietton, F; Petosa, C; Spittler, D; Zala, N; Zhou, Y	1
Cantürk, Z; Çavuşoğlu, BK; Yurttaş, L	1
Ahangarkani, F; Aslani, N; Badali, H; Boekhout, T; Hagen, F; Kolecka, A; Meis, JF; Meyabadi, MF; Shokohi, T	1
Chen, CT; Huang, MC; Huang, YJ; Lin, HC; Shen, M	1
Alvarez-Moreno, C; Ariza, BE; Ceballos-Garzón, A; Cortes-Fraile, G; de la Hoz, A; Garzón, JR; Hernandez, C; Le Pape, P; Linares-Linares, MY; Morio, F; Parra-Giraldo, CM; Valderrama, SL	1
Bartoszewicz, M; Król, J; Nawrot, U	1
Folić, M; Janković, SM; Jović, Z; Kostić, M; Milovanović, D; Milovanović, J; Ružić Zečević, D; Stefanović, S	1
Coombs, GW; Dyer, JR; Gardam, DJ; Heath, CH; Pang, S	1
Barker, KS; Doorley, LA; Nishimoto, AT; Palmer, GE; Rogers, PD; Rybak, JM	1
Emami, S; Ghobadi, E; Hashemi, SM; Saednia, S	1
Guan, XM; Hu, YL; Li, D; Wang, LH; Weng, LX; Xu, ZH; Yang, DL; Yin, ZX; Zeng, GS; Zhang, YQ	1
Abdolrasouli, A; Armstrong-James, D; Ashman, J; Chakrabarti, A; Colley, T; Dhaliwal, M; Ito, K; Kaur, H; Rapeport, G; Rudramurthy, SM; Schelenz, S; Strong, P	1
Arora, R; Chaudhary, SC; Kumar, V; Sawlani, KK	1
Chu, HY; Fredricks, DN; Jain, R; Pottinger, P; Xie, H	1
Hamada, Y; Hirayama, T; Ichibe, Y; Katori, Y; Kuroyama, M; Okuma, R; Takahashi, S	1
Averette, AF; Chen, YL; Heitman, J; Lehman, VN; Perfect, JR	1
Cuenca-Estrella, M; de Lucas, MP; Fusco-Almeida, AM; Lozano, E; Mendes-Giannini, MJ; Mesa-Arango, AC; Scorzoni, L; Zaragoza, O	1
Barrett, DM; Gerber, JS; Larru, B	1
Hatipoglu, H; Hatipoglu, N	1
Coste, A; Eddouzi, J; Ischer, F; Kelly, S; Manai, M; Parker, JE; Sanglard, D; Vale-Silva, LA	1
Chang, CL; Jang, HC; Jang, MJ; Kim, MN; Kim, SH; Lee, HS; Lee, K; Lee, MK; Lee, WG; Ryang, DW; Shin, JH; Shin, MG; Song, ES; Suh, SP	1
Castanheira, M; Jones, RN; Messer, SA; Pfaller, MA; Rhomberg, PR	1
Arakawa, S; Fujisawa, M; Osawa, K; Shigemura, K; Yoshida, H	1
Ballot, DE; Bosman, N; Cooper, PA; Nana, T; Ramdin, T	1
Benjamin, DK; Ericson, J; Manzoni, P	1
Andes, DR; Diekema, D; Lepak, AJ; Marchillo, K; VanHecker, J	1
Boral, OB; Cağatay, P; Keçeli, SA; Sonmez, N; Tamer, GS; Willke, A	1
Chen, SC; Meyer, W; Middleton, PG	1
Pea, F	1
Bierings, MB; Boelens, JJ; Gerhardt, CE; Hol, JA; Lindemans, CA; Versluys, AB; Wildt de, A; Wolfs, TF	1
Dorazilova, Z; Maly, J; Netuka, I; Pirk, J; Szarszoi, O	1
Gamaletsou, MN; Walsh, TJ	1
Cuenca-Estrella, M; Escribano, P; Guinea, J; Martín-Mazuelos, E; Pemán, J; Sánchez-Reus, F; Zaragoza, Ó	1
Forst, T; Goldenberg, R; Guthrie, R; Meininger, G; Stein, P; Vijapurkar, U; Yee, J	1
Arendrup, MC; Cuenca-Estrella, M; Hope, WW; Lass-Flörl, C	1
Cevallos, V; Hoover, C; Jeng, BH; Keenan, JD; Layer, N; Maxwell, AJ	1
Castanheira, M; Dietrich, RR; Jones, RN; Messer, SA; Pfaller, MA; Rhomberg, PR	1
Angelova, O; Auberger, J; Ditlbacher, A; Lackner, M; Lass-Flörl, C; Nachbaur, D; Orth-Höller, D	1
Azie, N; Ghannoum, M; Schmitt-Hoffmann, AH; Viljoen, J	1
Healy, JR; Kraft, WK; Moore, JN	1
Carver, PL; Pettit, NN	1
Gou, C; Li, C; Li, XZ; Li, YR; Liu, HY; Liu, JC; Piao, HR; Zhang, ML; Zheng, CJ	1
Capilla, J; Fothergill, AW; Guarro, J; Sanchis, M; Sutton, DA; Wiederhold, N	1
Coste, AT; Sanglard, D	1
Antonelli, M; Bassetti, M; Calandra, T; Roberts, JA; Vincent, JL	1
Arslan, U; Dagi, HT; Findik, D; Senkeles, C	1
Angiolella, L; Castagnola, M; Iavarone, F; Leone, C; Marzano, V; Vavala, E; Vitali, A	1
Mittal, A; Paliwal, S; Sharma, M; Sharma, S; Singh, A; Tilak, A; Tripathi, N	1
Bergeron, MG; Boily, MJ; Boissinot, M; Boudreau, DK; Maheux, AF; Ouellette, M; Pelletier, R; Picard, FJ; Piché, Y; Roy, PH; Sellam, A; Trépanier, H	1
Abid, M; Aneja, B; Azam, A; Irfan, M; Jairajpuri, MA; Kapil, C; Kavanagh, K; Maguire, R; Manzoor, N; Rizvi, MM	1
Guo, H; Jiang, L; Li, DM; Li, SX; Song, YJ; Zhang, H; Zhao, YJ; Zhu, KJ	1
DeRemer, DL; Fisher, JF; Forseen, C; Jillella, AP; Steele, JC; Ustun, C	1
Zaas, AK	1
Ayala, J; Elizondo, M; González, GM	1
Dolande, M; Panizo, MM; Reviákina, V; Selgrad, S	1
Bosch, M; Cantón, E; Espinel-Ingroff, A; Gobernado, M; Pemán, J; Valentín, A	1
Hollenbach, E	1
Hoppe-Tichy, T; Lichtenstern, C; Störzinger, D; Swoboda, S; Weigand, MA	1
Kishel, JJ; Sivik, J	1
Gafter-Gvili, A; Goldberg, E; Leibovici, L; Paul, M; Vidal, L	1
Espinel-Ingroff, A; Hockey, H; Johnson, E; Szekely, A; Troke, P	1
Aronoff, DM; Malani, AN	1
Alexander, BD; Daly, JS; Graybill, JR; Hardalo, CJ; Patino, H; Perfect, JR; Restrepo, A; Tobón, AM	1
Choi, CW; Joo, SI; Kim, BS; Kim, EC; Kim, TU; Kim, YK; Lee, KM; Lee, YS; Yoo, JI; Yun, SH	1
Calandra, T; Eggimann, P; Playford, EG	1
Denning, DW; Majithiya, J; Parmar, A; Sharp, A; Warn, PA	1
da Silva, CF; Dalla Costa, T; de Araujo, BV; Haas, SE	1
Cubillos, GF; Kett, DH	1
Boyken, L; Diekema, DJ; Hollis, RJ; Jones, RN; Kroeger, J; Messer, SA; Pfaller, MA; Tendolkar, S	1
Almirante, B; Pemán, J	1
Aher, NG; Bhat, MK; Kumar, A; Mishra, NN; Pore, VS; Sharma, A; Shukla, PK	1
Nawrot, U; Nowicka, J; Wlodarczyk, K	1
Auberger, J; Bellmann, R; Bellmann-Weiler, R; Joannidis, M; Lass-Flörl, C; Stein, M; Weiler, S	1
Enache-Angoulvant, A; Girard, A; Hennequin, C; Poirot, JL	1
Naeger-Murphy, N; Pile, JC	1
Chakrabarti, A; Chatterjee, SS; Rao, KL; Shivaprakash, MR; Singh, R; Singhi, S; Varma, SC; Zameer, MM	1
Marti, J	1
Asari, S; Iwatani, Y; Nishi, I; Sunada, A; Toyokawa, M	1
Fanci, R	1
Kim, SD; Lee, JJ; Lee, SJ	1
Clancy, CJ; Derendorf, H; Li, Y; Nguyen, MH; Schmidt, S; Zhong, L	1
Kida, M	1
Amrein, C; Benammar, M; Berge, M; Billaud, EM; Boussaud, V; Chevalier, P; Guillemain, R; Lefeuvre, S	1
Danzi, M; Marino, A; Mungiguerra, M; Pisano, L; Ricciardi, AM; Ricciardi, R	1
De Carolis, E; Fadda, G; Fiori, B; Florio, AR; La Sorda, M; Martucci, R; Posteraro, B; Sanglard, D; Sanguinetti, M	1
Pérez, P; Piñar, D; Quiles, JA; Reus, S	1
Denning, DW; Hope, WW; Majithiya, J; Parmar, A; Sharp, A; Warn, PA	1
Bulut, Y; Günday, E; Güven, M; Yenişehirli, G	1
Iida, T; Kagoshima, Y; Kamai, Y; Konosu, T; Mori, M; Shibayama, T; Suzuki, E	1
Guarro, J; Mariné, M; Pastor, FJ; Serena, C	1
Berger, N; Bonatti, H; Geltner, C; Grif, K; Lass-Flörl, C; Lechner, M; Margreiter, R; Stelzmueller, I	1
Becker, J; Davison, J; Hu, W; Jiang, B; Kauffman, S; Martel, N; Martin, CE; Ocampo, P; Oh, C; Roemer, T; Sillaots, S; Trosok, S; Veillette, K; Wang, H; Xu, D; Yang, M; Zhang, L	1
Kang, CI; Mandrekar, JN; Patel, R; Rouse, MS; Steckelberg, JM	1
Andrade, SE; Elizondo, M; González, GM; Portillo, OJ; Robledo, M; Rodríguez, C; Uscanga, GI	1
Avolio, M; Bruschetta, G; Camporese, A; De Rosa, R; Grosso, S	1
Fung, CP; Lee, N; Lee, SC; Lo, HJ; See, LC	1
Costa, CR; de Aquino Lemos, J; de Fátima Lisboa Fernandes, O; do Rosário Rodrigues Silva, M; Hasimoto e Souza, LK; Jesuíno, RS; Passos, XS	1
Amorim, CS; Briones, MR; Colombo, AL; Gonçalves, SS; Melo, AS; Nucci, M; Padovan, AC	1
Black, TA; Chau, AS; Cornely, OA; Mann, PA; McNicholas, PM; Mendrick, C; Patel, R; Patino, H; Ullmann, AJ	1
Damon, L; Guglielmo, BJ; Hwang, J; Kaplan, L; Linker, C; Martin, T; O'Malley, R; Sharma, M; Working, M	1
Elizondo, M; Garza-González, E; González, GM; González, JG	1
Guarro, J; Mariné, M; Pastor, FJ	1
Azeredo, J; Henriques, M; Martins, M; Negri, M; Oliveira, R; Svidzinski, TI	1
Al-Badriyeh, D; Davies, GE; Kong, D; Leung, L; Stewart, K	1
Bertout, S; Bourgeois, N; Bousquet, PJ; Dehandschoewercker, L; Lachaud, L; Rispail, P	1
Graninger, W; Kratzer, C; Lassnigg, A; Presterl, E; Tobudic, S	1
Almela, M; Marco, F; Martínez, JA; Mensa, J; Ortega, M; Pitart, C; Soriano, A	1
Adiri, Y; Karatela, S; Lyon, GM; Sunay, S	1
Furuya, A; Ida, K; Kato, M; Koh, K; Okamoto, T; Takita, J	1
Diekema, DJ; Ellis, D; Fu, W; Gibbs, DL; Ling, TA; Newell, VA; Pfaller, MA; Rodloff, A; Tullio, V	1
Besse, B; Hennequin, C; Le Pape, P; Loge, C; Morio, F	1
Barton, R; Bijie, H; Bille, J; Chang, SC; da Luz Martins, M; Diekema, DJ; Duse, A; Dzierzanowska, D; Ellis, D; Finquelievich, J; Gibbs, DL; Gould, I; Gur, D; Hoosen, A; Lee, K; Mallatova, N; Mallie, M; Newell, VA; Peng, NG; Petrikos, G; Pfaller, MA; Santiago, A; Trupl, J; VanDen Abeele, AM; Wadula, J; Zaidi, M	1
López-Martínez, R	1
King, AL; Massey, HD; Stolk, MJ	1
Odio, CM	1
Kagoshima, Y; Kamai, Y; Kobayashi, N; Konosu, T; Kubota, M; Mori, M; Shibayama, T; Suzuki, E	1
Hou, Z; Li, C; Liu, G; Liu, Z; Lu, M; Sha, X; Tan, D; Xie, J; Xie, Y	1
Cisneros-Lanuza, A; Díaz-Llopis, M; Duch-Samper, A; Hurtado-Sarrió, M; Peman-Garcíia, J; Vazquez-Polo, A	1
Cordonnier, C; Cornely, OA; Flückiger, U; Frêre, P; Gachot, B; Heinz, WJ; Herbrecht, R; Lass-Flörl, C; Maertens, J; Marchetti, O; Ribaud, P; Thiebaut, A	1
Fujisawa, T; Kanai, K; Kawakami, K; Kuroyanagi, J; Morita, C; Sugimoto, Y; Suzuki, T; Takemura, M	1
Cárdenes, D; Carrillo-Muñoz, AJ; Eraso, E; Estivill, D; Giusiano, G; Guardia, C; Hernández-Molina, JM; Marcos-Arias, C; Ortiz-Maestro, O; Quindós, G; Santos, P; Tur-Tur, C	1
Gyo, K; Hato, N; Hinohira, Y; Hyodo, J; Takahashi, H; Ugumori, T; Wakisaka, H	1
Boyken, L; Diekema, DJ; Hollis, RJ; Kroeger, J; Messer, SA; Pfaller, MA; Tendolkar, S	1
Ko, KS; Lee, JY; Peck, KR; Song, JH	1
Azevedo, AC; Bizerra, FC; Colombo, AL; da Matta, DA; de Almeida, LP; Rosas, R	1
Espinosa, C; García-Vázquez, E; Gómez, J; Hernández, A; Ruiz, J	1
Boyken, L; Diekema, DJ; Espinel-Ingroff, A; Hollis, RJ; Kroeger, J; Messer, SA; Pfaller, MA; Tendolkar, S	1
Carrillo-Muñoz, AJ; Del Valle, O; Eraso, E; Estivill, D; Giusiano, G; Guardia, C; Hernández-Molina, JM; Quindós, G; Santos, P; Tur-Tur, C	1
Bourgeois, N; Crouzet, J; Lachaud, L; Picard, E; Sotto, A	1
Flynn, HW; Liggett, PE; Scartozzi, R; Tom, D	1
Katragkou, A; Roilides, E	1
Alexander, BD; Andes, D; Arendrup, MC; Brown, SD; Chaturvedi, V; Diekema, DJ; Espinel-Ingroff, A; Fowler, CL; Ghannoum, MA; Johnson, EM; Knapp, CC; Motyl, MR; Ostrosky-Zeichner, L; Pfaller, MA; Walsh, TJ	1
Direkze, S; Gant, V; Kibbler, C; Mansour, M; Peggs, KS; Rodriguez-Justo, M	1
George, J; Reboli, AC	1
Dag, I; Kiraz, N; Oz, Y	1
Castanheira, M; Diekema, DJ; Jones, RN; Messer, SA; Pfaller, MA	1
da Silva, CM; de Carvalho Parahym, AM; de Oliveira, NT; Filho, GA; Leão, MP; Macario, MC; Neves, RP	1
Bassetti, M; Molinari, MP; Mussap, M; Nicco, E; Taramasso, L; Viscoli, C	1
Demitrovicova, A; Kisac, P; Krcmery, V	1
Fortún, J	1
Arancia, S; Arruda, DC; Ciociola, T; Conti, S; D'Adda, T; De Bernardis, F; Gabrielli, E; Galati, S; Magliani, W; Pericolini, E; Pertinhez, TA; Pinto, MR; Polonelli, L; Spisni, A; Travassos, LR; Vecchiarelli, A; Zanello, PP	1
Bedin, M; D'Angelo, M; Gion, M; Grandesso, S; Mazzuccato, S; Sapino, B; Solinas, M	1
Lacroix, C; Le Pape, P; Miegeville, M; Morio, F; Pagniez, F	1
Cantón, E; Martínez, JP; Pemán, J; Valentín, A	1
Dag, I; Kiraz, N; Kiremitci, A; Metintas, S; Oz, Y	1
Baden, LR; Boukedes, S; Camp, PC; Dietzek, A; Fuhlbrigge, AL; Goldberg, HJ; Issa, NC; Koo, S; Kubiak, DW; Marty, FM	1
Maack, KH; Tarp, B	1
Bader, O; Gross, U; Hull, CM; Kelly, DE; Kelly, SL; Parker, JE; Warrilow, AG; Weig, M	1
Denes, E; Dupon, M; Fiorenza, F; Megherbi, M; Saint-Marcoux, F; Weinbreck, P	1
Chang, YF; Lee, FL; Lee, SM; Yang, CS	1
Choi, HJ; Ju, MY; Jung, SI; Kim, SH; Lee, K; Lee, WG; Park, YJ; Shin, JH	1
Borowiec-Chłopek, Z; Czepita, D; Giedrys-Kalemba, S; Karczewicz, D; Kot, J; Lachowicz, E	1
Datta, S; Goel, N; Oberoi, JK; Prasad, K; Raveendran, R; Wattal, C	1
Ichihara, S; Murasaki, C; Ohwada, J; Shimma, N; Umeda, I; Yamazaki, T	1
Darouiche, RO; Kontoyiannis, DP; Lewis, RE; Prince, RA; Raad, II	1
Danielsen, R; Einarsdóttir, HM; Gottfredsson, M	1
Fukuda, H; Hayase, T; Ichihara, S; Isshiki, Y; Mizuguchi, E; Ohwada, J; Oikawa, N; Sakaitani, M; Shimma, N; Shiratori, Y; Tsukazaki, M; Umeda, I; Yamazaki, T	1
Fukuoka, T; Hosokawa, T; Kamai, Y; Kubota, M; Kuwahara, S; Maeda, N; Shibayama, T; Uchida, K; Yamaguchi, H	1
Andes, D; Conklin, R; Marchillo, K; Stamstad, T	2
Kontoyiannis, DP; Mantadakis, E; Samonis, G	1
Krawczyk, E; Luczak, M; Rokosz, A; Sulik-Tyszka, B; Swoboda-Kopec, E; Wroblewska, M	1
Boyken, L; Diekema, DJ; Hollis, RJ; Messer, SA; Pfaller, MA	1
Bayer, A; Edwards, JE; Rieg, G; Spellberg, B	1
Ruhnke, M	1
de la Torre-Cisneros, J; DuPont, B; Espinel-Ingroff, A; Greenberg, RN; Johnson, E; Just-Nübling, G; Lutsar, I; Marr, KA; Perfect, JR; Schlamm, HT; Walsh, TJ	1
Armstrong, D; Cross, EW; Perlin, DS; Safdar, A	1
Boyken, L; Diekema, DJ; Hollis, RJ; Messer, SA; Pfaller, MA; Tendolkar, S	2
Ullmann, AJ	1
Fung, HB; Jeu, L; Lyakhovetskiy, AG; Piacenti, FJ	1
Almela, M; Danés, C; de la Bellacasa, JP; Espasa, M; Jiménez de Anta, MT; Jurado, A; Marco, F; Martínez, JA; Mensa, J	1
Benito, R; Gil, J; Ramírez de Ocáriz, I; Rezusta, A; Rubio Calvo, MC	1
MOM, AM	1
BUCK, A; HEITE, HJ; LEHMANN, C	1
Dromer, F; Lamer, C; Le Guillou, JL; Le Jouan, M; Martinez, V; Tod, M	1
Barbour, N; Bronson, JJ; Chen, CP; Clark, J; Connolly, TP; Dali, M; Gao, Q; Golik, J; Huang, S; Hudyma, TW; Kang, SH; Knipe, J; Lamb, L; Mathew, M; Matiskella, JD; Medin, I; Mosure, K; Tejwani, R; Ueda, Y; Varia, S; Venkatesh, S; Zheng, M	1
Kullberg, BJ; Ostrosky-Zeichner, L; Oude Lashof, AM; Rex, JH	1
Bliss, JM; Gigliotti, F; Wellington, M	1
Baron, EJ; Colombo, AL; de Bedout, C; del Palacio, A; Gibbs, DL; Girmenia, C; Hazen, KC; Sanchez-Sousa, A	1
Fujihara, N; Ichiyama, S; Iinuma, Y; Kudo, T; Saito, T; Takakura, S	1
Andes, D; Cacciapuoti, A; Conklin, R; Ezzet, F; Krishna, G; Loebenberg, D; Marchillo, K	1
Espinel-Ingroff, A; Holliday, N; Killian, SB; Knapp, CC; Messer, SA; Pfaller, M	1
Casal, M; Charriel, G; Linares, MJ; Solís, F	1
Boyken, L; Diekema, DJ; Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA	1
Dupont, B	1
Bastié, JN; Bretagne, S; Castaigne, S; Chehata, S; Cordonnier, C; Kuentz, M; Maury, S; Pautas, C; Ribaud, P	1
Innes, JR; Moss, PJ; Thaker, HR; Varma, D; Wedgwood, K	1
Rubin, ZA; Somani, J	1
Nolard, N; Swinne, D; Van der Flaes, M; Watelle, M	1
Almoujahed, MO; Baran, J; Riederer, K	1
Bocanegera, R; Colombo, AL; Gonzalez, GM; Graybill, JR; Hernandez, S; McCarthy, DI; Najvar, LK	1
Drago, M; Morace, G; Scaltrito, MM	1
Cuenca-Estrella, M; Garcia-Effron, G; Gomez-Lopez, A; Mellado, E; Rodriguez-Tudela, JL	1
Bernhardt, H; Bernhardt, J; Knoke, M; Ludwig, K	1
Cheng, HH; Lo, HJ; Yang, YL	1
Balajee, SA; Englund, JA; Fredricks, DN; Imhof, A; Marr, KA	1
Kleinpeter, MA	1
Espinel-Ingroff, A; Jones, RN; Pfaller, MA	1
Jones, AL; Pai, MP	1
D'Antonio, D; Di Bonaventura, G; Picciani, C; Piccolomini, R; Spedicato, I	1
Arango, M; Correa, AL; de Bedout, C; Restrepo, A; Tobón, AM	1
Carrilero, MJ; Granados, JM; Puerto, N	1
Friedman, GS; Mathis, AS; Shah, NK	1
Bansal, M; Fealy, S; Khazzam, M	1
Perfect, JR	3
Marr, K	1
Breit, SM; Grand, MG; Hariprasad, SM; Mieler, WF; Mills, MD; Shah, GK	1
Cacciapuoti, A; Gurnani, M; Halpern, J; Loebenberg, D; Norris, C; Patel, R	1
Marr, KA	1
Balwierz, W	1
Fabry, K; Nelen, G; Verheyden, F	1
Böhme, A; Haas, A; Maschmeyer, G	1
Jacobs, RF; Maples, HD; Muldrew, KM; Stowe, CD	1
Jang, GJ; Kim, KS; Lee, WK; Shin, WS	1
Kofla, G; Ruhnke, M	1
Hoshiko, S; Ohtsuka, K; Okutomi, T; Takahata, S; Uchida, K; Yamaguchi, H	1
Aguado, JM; Cisneros, JM; Díaz Pedroche, C; Lumbreras, C	1
Barchiesi, F; Cuenca-Estrella, M; Espinel-Ingroff, A; Fothergill, A; Pfaller, MA; Rinaldi, M; Rodriguez-Tudela, JL; Verweij, PE	1
Bishara, J; Peled, N; Samra, Z; Yardeni, M	1
Argaud, L; Martin, O; Mohammedi, I; Piens, MA; Robert, D; Thiebaut, A	1
Bennett, F; Cacciapuoti, A; Ganguly, AK; Girijavallabhan, VM; Hare, RS; Jao, E; Liu, YT; Loebenberg, D; Lovey, RG; Menzel, F; Moss, E; Nomeir, A; Patel, NM; Pike, R; Pinto, P; Saksena, AK; Wang, H	1
Nagino, K; Shirasawa, H	1
Chang, SC; Chen, YC; Hsieh, SM; Lee, HT; Pan, SC	1
Kumar, R; Naithani, R	1
Marik, PE; Raman, T	1
Choti, M; Magill, SS; Merz, WG; Sears, CL; Shields, C	1
Barchiesi, F; Bedini, A; Borghi, V; Codeluppi, M; Esposito, R; Guaraldi, G; Mussini, C; Rumpianesi, F; Venturelli, C	1
Kyo, T; Mikami, Y; Murayama, SY; Myoken, Y; Sugata, T	1
Carde, A; Faure, P; Papy, E; Ribaud, P; Touratier, S	1
Bal, AM	1
Andes, D; Chaturvedi, V; Diekema, DJ; Espinel-Ingroff, A; Ghannoum, MA; Johnson, EM; Odds, FC; Pfaller, MA; Rex, JH; Rinaldi, MG; Sheehan, DJ; Troke, P; Walsh, TJ; Warnock, DW	1
Gogate, J; Greaves, W; Isaacs, R; Nieto, L; Northland, R; Sanne, I; Skiest, DJ; Vazquez, JA	1
Klotz, SA	1
Castro-Orjales, MJ; Collell-Llach, MD; de la Torre-Fernández, MJ; Díaz-López, MD; León, C; López-Ciudad, V; Pérez de Juan-Romero, MA; Sanz-Rodríguez, C	1
Gribskov, JL; Kirby, KA; Marr, KA; Panackal, AA; Rinaldi, M; Staab, JF	1
Bosch, M; Cantón, E; de Llanos, R; Jarque, I; Molina, A; Pemán, J; Salavert, M	1
Alves, SH; Azevedo, AC; Boff, E; Da Matta, DA; Guarro, J; Loreto, ES; Santurio, JM	1
Anstead, GM; Graybill, JR; Martinez, M	1
Black, TA; Hare, R; Loebenberg, D; Mann, PA; McNicholas, PM; Mendrick, CA; Norris, CC; Patel, R; Sabatelli, F	1
Akova, M; Sahin, GO	1
Aperis, G; Mylonakis, E	1
Chen, E; Ostrosky-Zeichner, L; Paetznick, VL; Rodriguez, JR; Sims, CR	1
Baltch, AL; Bopp, LH; Michelsen, PB; Ritz, WJ; Smith, RP	1
Pemán, J; Zaragoza, R	1
Bäsecke, J; Glass, B; Perske, C; Rüchel, R	1
Kauffman, CA	1
Odds, FC	1
Barcs, I; Dóczi, I; Mestyán, G; Nagy, E; Nikolova, R; Puskás, E	1
Groll, AH; Walsh, TJ	1
Behringer, K; Cornely, OA; Krüger, K; Kurzai, O; Töx, U; Vehreschild, JJ; Wickenhauser, C	1
Lill, H; Voigt, C	1
Aperis, G; Mylonakis, E; Spanakis, EK	1
Manfredi, R; Sabbatani, S	1
Cao, YB; Cao, YY; Gao, PH; He, QQ; Jiang, YY; Liu, CM; Liu, WX; Quan, H; Wu, QY; Zhao, JX	1
Chang, SC; Diekema, DJ; Erzsebet, P; Gibbs, DL; Kibbler, C; Mendez, M; Newell, VA; Pfaller, MA	1
Colombo, AL; Diekema, DJ; Gibbs, DL; Kibbler, C; Newell, VA; Ng, KP; Pfaller, MA	1
Bille, J; Bolay, S; Buclin, T; Calandra, T; Decosterd, LA; Majcherczyk, PA; Marchetti, O; Nieth, V; Pascual, A; Sanglard, D	1
Carratalà, J; Garcia-Vidal, C	1
Alcoba-Flórez, J; Arévalo, MP; Arias, A; Moragues, MD; Pontón, J; Quindós, G; Salgado-Parreño, FJ	1
Anstead, GM; Boparai, N; Graybill, JR; Hare, R; Isaacs, R; Reynes, J; Skiest, DJ; Vazquez, JA; Ward, D	1
Corbett, JR; McKeown, PP; Tolland, JP	1
Benjamin, DK; Cotten, CM; Perfect, JR; Schell, WA; Smith, PB; Steinbach, WJ; Walsh, TJ	1
Boyken, LB; Diekema, DJ; Hollis, RJ; Kroeger, J; Messer, SA; Pfaller, MA; Tendolkar, S	1
Araújo, CR; Costa, CR; e Souza, LK; Fernandes, Ode F; Nascimento, ES; Passos, XS; Sales, WS; Silva, Mdo R	1
Avci, B; Cetinkaya, Z; Ermis, SS; Inan, UU; Kusbeci, T; Ozturk, F; Yavas, G	1
Easley, C; Kauffman, CA; Kirkpatrick, P; Malani, AN	1
Aoun, N; Baixench, MT; Bretagne, S; Dannaoui, E; Desnos-Ollivier, M; Garcia-Hermoso, D; Piketty, C; Ramires, S	1
Falusi, E; Gergely, L; Kardos, G; Majoros, L; McNicholas, PM; Sóczó, G	1
Cheng, S; Clancy, CJ; Derendorf, H; Li, Y; Nguyen, MH	1
Petrikkos, G; Skiada, A	1
Arendrup, MC; Denning, DW; Diekema, DJ; Pfaller, MA; Rex, JH	1
Winslow, DL	1
Evens, A; Frankfurt, O; Gordon, L; Mehta, J; Pi, J; Singhal, S; Tallman, M; Trifilio, S; Williams, S; Winter, J	1
Lewis, RE	1
Haas, A; Maschmeyer, G	1
Gleissner, B; Mansmann, V; Schilling, A; Seibold, M	1
Guarro, J; Pastor, FJ	1
Cesur, S; Kaynak, F; Ozçelik, B; Sipahi, B; Sultan, N	1
Gahn, B; Gramatzki, M; Repp, R; Schub, N	1
Chang, CL; Kim, MN; Kim, SH; Lee, HS; Lee, JS; Lee, K; Lee, WG; Ryang, DW; Shin, BM; Shin, JH; Shin, MG; Suh, SP; Uh, Y	1
Cantón, E; Carrillo-Muñoz, A; Espinel-Ingroff, A; Martín-Mazuelos, E; Martínez, JP; Pemán, J	1
Fung, HB; Schiller, DS	1
Khakoo, RA; Khan, FA; Slain, D	1
Alkorta, M; Eraso, E; Hernández-Almaraz, JL; Quindós, G; Sánchez-Vargas, LO; Villar-Vidal, M	1
Barchiesi, F; Maida, CM; Milici, ME; Scalise, G; Spreghini, E	1
Mian, P; Pagani, L; Spoladore, G; Vedovelli, C	1
Bille, J; Bolay, S; Buclin, T; Calandra, T; Marchetti, O; Pascual, A	1
Alffenaar, JW; Doedens, RA; Groninger, E; Kosterink, JG	1
Deresinski, S; Nagappan, V	1
Barnes, R; Colombo, A; Diekema, DJ; Finquelievich, J; Gibbs, DL; Newell, VA; Ng, KP; Pfaller, MA; Wadula, J	1
Berceanu, A; Herbrecht, R	1
Imhof, A; Misselwitz, B; Schneemann, M	1
Joshi, R; Kohli, V; Sachdev, P; Taneja, V	1
Graybill, JR; Lewis, JS	1
Barchiesi, F; Giannini, D; Maida, CM; Milici, ME; Orlando, F; Scalise, G; Spreghini, E; Tomassetti, S	1
Mercier, RC; Pai, MP; Samples, ML; Spilde, MN	1
Akşit, F; Kiraz, N; Kiremitçi, A; Oz, Y	1
Frampton, JE; Scott, LJ	1
Plempel, M	2
Janssen, PA; Van Cutsem, J; Van Gerven, F; Zaman, R	1
Givner, LB; Horn, CA; Peacock, JE; Pegram, PS; Washburn, RG	1
Anaissie, EJ; Uzun, O	1
Anaissie, EJ; Dignani, MC; Hachem, R; Karyotakis, NC	1
Graybill, JR; Holmberg, JD; Luther, MF; Najvar, LK	1
Anaissie, EJ; Dignani, MC; Karyotakis, NC	1
Gearhart, MO	1
Atkinson, BA; Bocanegra, R; Colombo, AL; Graybill, JR	1
Gantz, NM; Hyder, SS; Manjon, JE	1
Lee, JW; Walsh, TJ	1
Hayashi, R; Itoh, K; Matsushita, Y; Okonogi, K; Tamura, N; Tasaka, A; Teranishi, K	1
Hayashi, R; Itoh, K; Matsushita, Y; Okonogi, K; Tamura, N; Tasaka, A	1
Kozuki, K; Miyauchi, H; Ohashi, N; Tanio, T	2
Hata, K; Katsu, K; Kimura, J; Miki, H; Nakamura, T; Toyosawa, T	1
Hata, K; Katsu, K; Kimura, J; Miki, H; Moriyama, M; Toyosawa, T	1
Correa, A; Graybill, JR; James, P; Luther, MF; Najvar, LK	1
Annen, N; Araki, H; Fujimaki, K; Hayakawa, H; Hori, R; Imaizumi, H; Narita, H; Nishida, N; Shimizu, K; Watanbe, Y; Yamamoto, S; Yotsuji, A	1
Cartledge, JD; Clumeck, N; De Wit, S; Denning, DW; Dupont, B; Gazzard, BG; Hawkins, DA	1
Hollis, RJ; Pfaller, MA; Zhang, J	1
Cutright, JL; Fidel, PL; Sobel, JD	1
Kakinuma, H; Kaku, Y; Naito, T; Tsukada, I; Tsuruoka, A; Yanagisawa, M	1
Bouza, E; Muñoz, P	1
Denning, DW; Law, D; Moore, CB	1
Jones, RN; Marco, F; Messer, S; Pfaller, MA	1
Kakinuma, H; Kaku, Y; Naito, T; Nara, K; Tsukada, I; Tsuruoka, A; Yanagisawa, M	1
Algueró, M; Bartroli, J; Boncompte, E; Conte, L; Forn, J; García-Rafanell, J; Merlos, M; Ramis, J; Turmo, E; Vericat, ML	2
Brandt, ME; Doern, GV; Hajjeh, RA; Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA	1
Aoki, FH; Branchini, ML; Mikami, Y; Miyaji, M; Nishimura, K; Taguchi, H; Yamamoto, K; Yang, HC; Yazawa, K	1
Coleman, DC; Gee, S; Joly, S; Messer, SA; Pfaller, MA; Pujol, C; Soll, DR; Sullivan, DJ	1
Gregory, RK; Mortimer, PS; Powles, RL; Riley, U; Smith, ML; Treleaven, JG; Wotherspoon, A	1
Bhat, N; Ghannoum, MA; Okogbule-Wonodi, I; Sanati, H	1
Hayashi, R; Hosono, H; Itoh, K; Kitazaki, T; Matsushita, Y; Okonogi, K; Tamura, N; Tasaka, A	1
Coffman, S; Doern, GV; Fluit, AC; Hollis, RJ; Houston, A; Jones, RN; Messer, SA; Pfaller, MA; Sader, HS; Verhoef, J	1
Patterson, TF	1
Niki, Y	1
Antonacci, B; Arnold, B; Cacciapuoti, A; Corcoran, E; Halpern, J; Hare, RS; Loebenberg, D; Mendrick, C; Menzel, F; Michalski, M; Miller, GH; Moss, EL; Norris, C; Parmegiani, R; Raynor, K; Yarosh-Tomaine, T	1
Cassone, A; Girmenia, C; Martino, P; Monaco, M; Mondello, F; Santilli, S; Tuccinardi, C	1
Abdel-Rahman, SM; Sabo, JA	1
Bolmstrom, A; Houston, A; Jones, RN; Messer, SA; Mills, K; Pfaller, MA	1
Arikan, S; Kocagöz, S; Sancak, B; Unal, S; Uzun, O	1
Ernst, EJ; Hoffman, HL; Klepser, ME	1
Krcmery, V	1
Granier, F	1
Müller, FM; Weig, M	1
Karlsson, I; Kronvall, G	1
Czaika, V; Schmalreck, A; Schultze, W; Sterry, W; Tietz, HJ	1
Atwal, H; Daneshtalab, M; Furukawa, T; Gandhi, A; Higashitani, F; Khan, JK; Micetich, RG; Montaseri, H; Nishida, K; Poglod, M; Saito, H; Salama, SM; Simon, J; Uji, T; Unemi, N	1
Diekema, DJ; Fluit, AC; Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA; Sader, HS	1
Aguirrebengoa, K; Ally, R; Carosi, G; Dupont, B; Hodges, M; Kreisel, W; Romero, AJ; Schürmann, D; Troke, P	1
Bolmström, A; Jones, RN; Messer, SA; Mills, K; Pfaller, MA	1
Odds, FC; Sanglard, D	1
DE Carolis, E; Loranger, L; Marcotte, H; Pelletier, R	1
Diekema, DJ; Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA	1
Ghannoum, MA; Kuhn, DM	1
Habel, F; Hoban, D; Laverdiere, M; Restieri, C	1
Antonacci, B; Cacciapuoti, A; Hare, RS; Loebenberg, D; Menzel, F; Miller, GH; Moss, EL; Norris, C; Parmegiani, R; Yarosh-Tomaine, T	2
Konosu, T; Oida, S; Takeda, N; Tanaka, T; Yasuda, H	1
Sugar, AM	1
Ackerbauer, H; Meingassner, JG; Mieth, H; Petranyi, G; Schaude, M	1
Hector, RF; Yee, E	1
Ryley, JF; Ryley, NG	1
Bacher, J; Kelly, P; Lecciones, J; Lee, JW; Peter, J; Pizzo, PA; Thomas, V; Walsh, TJ	1
Konosu, T; Oida, S; Tajima, Y; Takeda, N; Yasuda, H	1
Bunin, N; Camitta, B	1
Cohen, J	1
Fukawa, H; Kodama, F; Maruta, A; Matsuzaki, M	1
Adachi, M; Ikeda, H; Kawanishi, M; Matsushima, T; Nakamura, J; Tanabe, J; Tano, Y; Tomizawa, S	1
Arai, S; Iguchi, K; Kamiya, H; Sakurai, M	1
Nito, H	1
Goto, H; Goto, M; Mori, H; Nakata, H; Oka, S; Shimada, K; Tokitsu, M	1
Hojo, H; Lin, KY; Torii, Y; Toyama, K; Tsuda, A; Yoshikawa, O	1
Ebe, T; Hamamoto, T; Hibiya, I; Inagaki, M; Isonuma, H; Kohara, T; Matsumura, M; Mori, T; Takahashi, M; Watanabe, K	1
Akahonai, Y; Ikemoto, H; Kasai, M; Kawamura, K; Mikuni, C; Mori, T; Taniuchi, A; Watanabe, K; Yoshida, K; Yoshida, T	1
Keil, TU	1
Mattie, H; van Furth, R; Van t Wout, JW	1
Bernard, DB; Farnham, H; Idelson, BA; Levine, J; Saunders, C; Sugar, AM	1
Goldberg, DJ; Green, ST; Kennedy, DH; McGuire, W; Nathwani, D	1
Ellis-Pegler, RB; Thomas, MG	1
Fisher, MA; Lee, PG; Tarry, WF	1
Durack, DT; Hobbs, MM; Perfect, JR; Wright, KA	1
Dave, J; Hickey, MM; Wilkins, EG	1
Corris, PA; Dark, JH; Freeman, R; Gould, FK; Kirk, AJ	1
Hirsch, HA	1
Thomason, JL	1
Polak, A	1
Beggs, WH; Bennett, RL; Hughes, CE; Tuna, IC	1
Drouhet, E; Dupont, B	1
Isalska, BJ; Stanbridge, TN	1
Drew, RH; Gallis, HA; Perfect, JR	1
Clayton, YM; Hay, RJ	1
Hendel, L; Kieffer, M; Stenderup, A; Svejgaard, E; Walsøe, I	1
Burke, J; Cope, NJ; Johnson, EM; von Fraunhofer, NA; Warnock, DW; Williams, EW	1
Brammer, KW; Marriott, MS; Richardson, K; Troke, PF	1
Andrews, RJ; Brammer, KW; Marriott, MS; Richardson, K; Troke, PF	1
Durack, DT; Perfect, JR; Savani, DV	1
Hopwood, V; Johnson, EM; Kennedy, CT; Smith, KJ; Van Cutsem, J; Vanden Bossche, H; Warnock, DW	1
Cobo, LM; Durack, DT; Perfect, JR; Savani, DV	1
Lefler, E; Stevens, DA	1

Reviews

73 review(s) available for triazoles and Candidiasis

Article	Year
Comparative effectiveness of amphotericin B, azoles and echinocandins in the treatment of candidemia and invasive candidiasis: A systematic review and network meta-analysis. Mycoses, 2021, Volume: 64, Issue:9 Topics: Amphotericin B; Antifungal Agents; Candidemia; Candidiasis; Candidiasis, Invasive; Echinocandins; Humans; Network Meta-Analysis; Randomized Controlled Trials as Topic; Triazoles	2021
Drug development challenges and strategies to address emerging and resistant fungal pathogens. Expert review of anti-infective therapy, 2017, Volume: 15, Issue:6 Topics: Antifungal Agents; Biomarkers; Candida; Candidiasis; Clinical Trials as Topic; Drug Design; Drug Resistance, Fungal; Echinocandins; Glycosides; Humans; Invasive Fungal Infections; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles; Triterpenes	2017
Clinical Pharmacokinetics of Second-Generation Triazoles for the Treatment of Invasive Aspergillosis and Candidiasis. European journal of drug metabolism and pharmacokinetics, 2019, Volume: 44, Issue:2 Topics: Animals; Antifungal Agents; Aspergillosis; Candidiasis; Drug Interactions; Humans; Triazoles; Voriconazole	2019
Current advances of triazole alcohols derived from fluconazole: Design, in vitro and in silico studies. European journal of medicinal chemistry, 2019, May-15, Volume: 170 Topics: Animals; Antifungal Agents; Candida; Candidiasis; Drug Design; Drug Discovery; Fluconazole; Fungi; Humans; Models, Molecular; Mycoses; Triazoles	2019
Bibliographical investigation (domestic and overseas) on the treatment of endogenous Candida endophthalmitis over an 11-year period. Medical mycology journal, 2013, Volume: 54, Issue:1 Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Endophthalmitis; Female; Fluconazole; Humans; Infant; Japan; Male; MEDLINE; Middle Aged; Pyrimidines; Severity of Illness Index; Time Factors; Treatment Outcome; Triazoles; Vitrectomy; Voriconazole; Young Adult	2013
Combination antifungal therapy for invasive fungal infections in children and adults. Expert review of anti-infective therapy, 2013, Volume: 11, Issue:5 Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Caspofungin; Child; Cryptococcosis; Cryptococcus; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Pyrimidines; Triazoles; Voriconazole	2013
Background changing patterns of neonatal fungal sepsis in a developing country. Journal of tropical pediatrics, 2013, Volume: 59, Issue:6 Topics: Antifungal Agents; Birth Weight; Candida; Candidemia; Candidiasis; Drug Resistance, Fungal; Female; Fluconazole; Humans; Incidence; Infant, Newborn; Male; Microbial Sensitivity Tests; Pyrimidines; Risk Factors; Socioeconomic Factors; South Africa; Treatment Outcome; Triazoles; Voriconazole	2013
Old and new: appropriate dosing for neonatal antifungal drugs in the nursery. Early human development, 2013, Volume: 89 Suppl 1 Topics: Amphotericin B; Antifungal Agents; Candidiasis; Deoxycholic Acid; Dose-Response Relationship, Drug; Drug Combinations; Echinocandins; Fluconazole; Humans; Infant, Newborn; Infant, Newborn, Diseases; Intensive Care Units, Neonatal; Neonatology; Pyrimidines; Triazoles; Voriconazole	2013
Fungal infections and treatment in cystic fibrosis. Current opinion in pulmonary medicine, 2013, Volume: 19, Issue:6 Topics: Antibodies, Fungal; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Bronchoalveolar Lavage Fluid; Candida; Candidiasis; Cystic Fibrosis; DNA, Fungal; Female; Humans; Itraconazole; Male; Pyrimidines; Scedosporium; Sputum; Triazoles; Vital Capacity; Voriconazole	2013
Current pharmacological concepts for wise use of echinocandins in the treatment of Candida infections in septic critically ill patients. Expert review of anti-infective therapy, 2013, Volume: 11, Issue:10 Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Critical Illness; Drug Administration Schedule; Drug Dosage Calculations; Drug Therapy, Combination; Echinocandins; Humans; Practice Guidelines as Topic; Pyrimidines; Sepsis; Triazoles; Voriconazole	2013
Fungal infections associated with long-term mechanical circulatory support-diagnosis and management. Journal of cardiac surgery, 2014, Volume: 29, Issue:1 Topics: Antifungal Agents; Aspergillosis; Candidiasis; Fluconazole; Heart Failure; Heart-Assist Devices; Humans; Incidence; Mycoses; Pyrimidines; Risk Factors; Time Factors; Triazoles; Voriconazole	2014
Treatment of fungal disease in the setting of neutropenia. Hematology. American Society of Hematology. Education Program, 2013, Volume: 2013 Topics: Anemia, Aplastic; Antifungal Agents; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Fusariosis; Fusarium; Hematologic Neoplasms; Humans; Myelodysplastic Syndromes; Neutropenia; Pyrimidines; Scedosporium; Triazoles; Voriconazole	2013
Breakpoints for antifungal agents: an update from EUCAST focussing on echinocandins against Candida spp. and triazoles against Aspergillus spp. Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 2013, Volume: 16, Issue:6 Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Drug Resistance, Fungal; Echinocandins; Humans; Microbial Sensitivity Tests; Triazoles	2013
In brief: a new formulation of posaconazole (Noxafil). The Medical letter on drugs and therapeutics, 2015, Feb-02, Volume: 57, Issue:1461 Topics: Animals; Antifungal Agents; Aspergillosis; Candidiasis; Chemistry, Pharmaceutical; Humans; Triazoles	2015
Pharmacologic and clinical evaluation of posaconazole. Expert review of clinical pharmacology, 2015, Volume: 8, Issue:3 Topics: Animals; Antifungal Agents; Aspergillosis; Candidiasis; Chemistry, Pharmaceutical; Critical Illness; Delayed-Action Preparations; Humans; Mycoses; Triazoles	2015
Isavuconazole: A New Option for the Management of Invasive Fungal Infections. The Annals of pharmacotherapy, 2015, Volume: 49, Issue:7 Topics: Animals; Antifungal Agents; Aspergillosis; Candidemia; Candidiasis; Candidiasis, Invasive; Clinical Trials as Topic; Drug Resistance, Fungal; Humans; Nitriles; Pyridines; Triazoles; Voriconazole	2015
Diagnosis and management of invasive candidiasis in the ICU: an updated approach to an old enemy. Critical care (London, England), 2016, May-27, Volume: 20, Issue:1 Topics: Antifungal Agents; Candida albicans; Candidiasis; Disease Management; Fluconazole; Humans; Intensive Care Units; Triazoles	2016
Echinocandins: a wealth of choice--how clinically different are they? Current opinion in infectious diseases, 2008, Volume: 21, Issue:4 Topics: Antifungal Agents; Aspergillosis; Candidiasis; Chemoprevention; Drug Therapy, Combination; Echinocandins; Fungi; Humans; Triazoles	2008
Invasive candidiasis in the ICU: evidence based and on the edge of evidence. Mycoses, 2008, Volume: 51 Suppl 2 Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Intensive Care Units; Itraconazole; Pyrimidines; Risk Factors; Triazoles; Voriconazole	2008
Treatment of invasive candidal infections: systematic review and meta-analysis. Mayo Clinic proceedings, 2008, Volume: 83, Issue:9 Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Confidence Intervals; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Odds Ratio; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole	2008
Antifungals in the ICU. Current opinion in infectious diseases, 2008, Volume: 21, Issue:6 Topics: Antifungal Agents; Candida; Candidiasis; Critical Illness; Echinocandins; Fluconazole; Humans; Intensive Care Units; Triazoles	2008
Anidulafungin in the treatment of patients with invasive candidiasis. International journal of antimicrobial agents, 2008, Volume: 32 Suppl 2 Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Echinocandins; Fluconazole; Humans; Pyrimidines; Triazoles; Voriconazole	2008
[Advances in the diagnosis and treatment of yeast infections: role of the new antifungal agents]. Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 13 Topics: Amphotericin B; Antibodies, Fungal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Fungal; Candida; Candidiasis; Clinical Trials as Topic; DNA, Fungal; Drug Interactions; Echinocandins; Fungemia; Humans; Mycology; Mycoses; Triazoles; Yeasts	2008
Clinical indications for newer antifungal agents. Journal of hospital medicine, 2009, Volume: 4, Issue:2 Topics: Antifungal Agents; Aspergillosis; Azoles; Candidiasis; Drug Therapy; Echinocandins; Endemic Diseases; Humans; Mycoses; Neutropenia; Triazoles; Zygomycosis	2009
Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature. Diagnostic microbiology and infectious disease, 2010, Volume: 66, Issue:4 Topics: Amino Acid Substitution; Antifungal Agents; Candida albicans; Candidiasis; Cytochrome P-450 Enzyme System; DNA, Fungal; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation, Missense; Pyrimidines; Sequence Analysis, DNA; Sterol 14-Demethylase; Triazoles; Voriconazole	2010
Candidosis, a new challenge. Clinics in dermatology, 2010, Mar-04, Volume: 28, Issue:2 Topics: Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Microbial; Drug Therapy, Combination; Echinocandins; Humans; Imidazoles; Naphthalenes; Nystatin; Terbinafine; Triazoles	2010
[Antifungal therapy for infants, children and adolescents with suspected or documented invasive fungal infection]. Drugs of today (Barcelona, Spain : 1998), 2010, Volume: 46 Suppl C Topics: Adolescent; Antifungal Agents; Antineoplastic Agents; Candidiasis; Child; Child, Preschool; Fever; Humans; Infant; Infant, Newborn; Mycoses; Neoplasms; Neutropenia; Triazoles	2010
[Nosocomial candidemia: new challenges of an emergent problem]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2010, Volume: 23, Issue:4 Topics: Candida; Candidiasis; Cross Infection; Drug Resistance, Fungal; Guidelines as Topic; Humans; Prognosis; Triazoles	2010
Best practice in treating infants and children with proven, probable or suspected invasive fungal infections. Current opinion in infectious diseases, 2011, Volume: 24, Issue:3 Topics: Antifungal Agents; Aspergillosis; Candidiasis; Child; Echinocandins; Fever of Unknown Origin; Humans; Infant; Mycoses; Pyrimidines; Triazoles; Voriconazole	2011
Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria. Diagnostic microbiology and infectious disease, 2011, Volume: 70, Issue:3 Topics: Antifungal Agents; Candida; Candidiasis; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2011
Anidulafungin: when and how? The clinician's view. Mycoses, 2012, Volume: 55, Issue:1 Topics: Anidulafungin; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Drug Resistance, Fungal; Drug Synergism; Drug-Related Side Effects and Adverse Reactions; Echinocandins; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2012
[Antifungal therapy update: new drugs and medical uses]. Enfermedades infecciosas y microbiologia clinica, 2011, Volume: 29 Suppl 5 Topics: Anidulafungin; Antifungal Agents; Aspergillosis; Candidiasis; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Early Diagnosis; Echinocandins; Humans; Immunocompromised Host; Lipopeptides; Micafungin; Mycoses; Randomized Controlled Trials as Topic; Salvage Therapy; Treatment Outcome; Triazoles	2011
Systemic mycoses in the immunocompromised host: an update in antifungal therapy. The Journal of hospital infection, 2003, Volume: 53, Issue:4 Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Candidiasis; Deoxycholic Acid; Drug Combinations; Echinocandins; Fungal Proteins; Humans; Immunocompromised Host; Mycoses; Peptides; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Triazoles	2003
[Voriconazole - applications and perspectives]. Mycoses, 2002, Volume: 45 Suppl 3 Topics: Antifungal Agents; Aspergillosis; Candidiasis; Humans; Microbial Sensitivity Tests; Mitosporic Fungi; Pyrimidines; Triazoles; Voriconazole	2002
Review of the safety, tolerability, and drug interactions of the new antifungal agents caspofungin and voriconazole. Current medical research and opinion, 2003, Volume: 19, Issue:4 Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Clinical Trials as Topic; Drug Interactions; Echinocandins; Humans; Lipopeptides; Peptides; Peptides, Cyclic; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole	2003
Voriconazole. Clinical therapeutics, 2003, Volume: 25, Issue:5 Topics: Animals; Antifungal Agents; Area Under Curve; Aspergillosis; Candidiasis; Child; Child, Preschool; Female; Fungi; Half-Life; Humans; Intestinal Absorption; Male; Microbial Sensitivity Tests; Pyrimidines; Randomized Controlled Trials as Topic; Scedosporium; Tissue Distribution; Triazoles; Voriconazole; Yeasts	2003
Antifungal pharmacotherapy for neonatal candidiasis. Seminars in perinatology, 2003, Volume: 27, Issue:5 Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Cross Infection; Echinocandins; Fluconazole; Flucytosine; Fungal Proteins; Fungemia; Humans; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Ketoconazole; Lipopeptides; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2003
[New antifungal agents: voriconazole and caspofungin]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2003, Volume: 10 Suppl 5 Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Child; Drug Interactions; Echinocandins; Humans; Lipopeptides; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2003
New options for the treatment of invasive fungal infections. Seminars in oncology, 2004, Volume: 31, Issue:2 Suppl 4 Topics: Adult; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Echinocandins; Female; Fungemia; Humans; Immunocompromised Host; Lipopeptides; Male; Middle Aged; Mycetoma; Mycoses; Neoplasms; Opportunistic Infections; Peptides; Peptides, Cyclic; Pyrimidines; Scedosporium; Triazoles; Voriconazole	2004
Successful treatment of Candida infections in peritoneal dialysis patients: case reports and review of the literature. Advances in peritoneal dialysis. Conference on Peritoneal Dialysis, 2004, Volume: 20 Topics: Aged; Antifungal Agents; Candidiasis; Catheters, Indwelling; Cefazolin; Female; Humans; Middle Aged; Peritoneal Dialysis; Peritonitis; Pyrimidines; Triazoles; Voriconazole	2004
Management of invasive mycoses in hematology patients: current approaches. Oncology (Williston Park, N.Y.), 2004, Volume: 18, Issue:13 Suppl 7 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Deoxycholic Acid; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Resistance, Fungal; Echinocandins; Fungal Proteins; Hematopoietic Stem Cell Transplantation; Humans; Liposomes; Mycoses; Neoplasms; Neutropenia; Peptides, Cyclic; Randomized Controlled Trials as Topic; Survival Analysis; Triazoles	2004
Use of newer antifungal therapies in clinical practice: what do the data tell us? Oncology (Williston Park, N.Y.), 2004, Volume: 18, Issue:13 Suppl 7 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Deoxycholic Acid; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Liposomes; Mycoses; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Triazoles; Voriconazole; Zygomycosis	2004
Combination antifungal therapy: where are we now, and where are we going? Oncology (Williston Park, N.Y.), 2004, Volume: 18, Issue:13 Suppl 7 Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Azoles; Candidiasis; Caspofungin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; In Vitro Techniques; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Pyrimidines; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Triazoles; Voriconazole	2004
Antifungal resistance: the clinical front. Oncology (Williston Park, N.Y.), 2004, Volume: 18, Issue:14 Suppl 1 Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Health Status; Humans; Lipopeptides; Peptides, Cyclic; Pyrimidines; Risk Factors; Thiazoles; Treatment Outcome; Triazoles; United States; Voriconazole	2004
Invasive Candida infections: the changing epidemiology. Oncology (Williston Park, N.Y.), 2004, Volume: 18, Issue:14 Suppl 1 Topics: Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Flucytosine; Fungemia; Humans; Incidence; Prevalence; Risk Factors; Triazoles; United States	2004
[Update on therapy of invasive mycoses in hematology and oncology]. Deutsche medizinische Wochenschrift (1946), 2005, Jun-03, Volume: 130, Issue:22 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Deoxycholic Acid; Drug Combinations; Echinocandins; Hematologic Neoplasms; Humans; Itraconazole; Lipopeptides; Liposomes; Mycoses; Organ Transplantation; Peptides, Cyclic; Pyrimidines; Risk Factors; Stem Cell Transplantation; Triazoles; Voriconazole; Zygomycosis	2005
Voriconazole: review of a broad spectrum triazole antifungal agent. Expert opinion on pharmacotherapy, 2005, Volume: 6, Issue:7 Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Cryptococcosis; Cyclic N-Oxides; Disease Models, Animal; Drug Resistance, Fungal; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Injections, Intravenous; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole	2005
[Voriconazole-medicalneeds, evidence, potential for the future]. Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology, 2005, Volume: 46, Issue:4 Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus; Biological Availability; Candida; Candidiasis; Guinea Pigs; Humans; Pyrimidines; Tissue Distribution; Triazoles; Voriconazole	2005
Fungal infections in bone marrow transplant recipients. Expert opinion on pharmacotherapy, 2006, Volume: 7, Issue:3 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Candidiasis; Caspofungin; Drug Administration Schedule; Echinocandins; Humans; Lipopeptides; Peptides, Cyclic; Postoperative Complications; Premedication; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole	2006
Treatment of invasive infections due to rare or emerging yeasts and moulds. Expert opinion on pharmacotherapy, 2006, Volume: 7, Issue:9 Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Clinical Trials as Topic; Drug Administration Schedule; Drug Resistance, Fungal; Drug Therapy, Combination; Fluconazole; Humans; Immunocompromised Host; Mucormycosis; Practice Guidelines as Topic; Pyrimidines; Triazoles; Voriconazole	2006
Newer triazole antifungal agents: pharmacology, spectrum, clinical efficacy and limitations. Expert opinion on investigational drugs, 2006, Volume: 15, Issue:6 Topics: Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Administration Schedule; Drug Evaluation, Preclinical; Drug Resistance, Fungal; Drug Therapy, Combination; Humans; Pyrimidines; Randomized Controlled Trials as Topic; Thiazoles; Triazoles; Voriconazole	2006
Invasive fungal infections in critically ill patients: different therapeutic options and a uniform strategy. Revista iberoamericana de micologia, 2006, Volume: 23, Issue:2 Topics: Amphotericin B; Antifungal Agents; Candidiasis; Critical Illness; Cross Infection; Deoxycholic Acid; Drug Combinations; Fluconazole; Humans; Intensive Care Units; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole	2006
Clinical efficacy of new antifungal agents. Current opinion in microbiology, 2006, Volume: 9, Issue:5 Topics: Antifungal Agents; Aspergillosis; Candidiasis; Clinical Trials as Topic; Diarrhea; Exanthema; Humans; Mycoses; Nausea; Peptides, Cyclic; Triazoles; Vomiting; Zygomycosis	2006
Drug evaluation: BAL-8557--a novel broad-spectrum triazole antifungal. Current opinion in investigational drugs (London, England : 2000), 2006, Volume: 7, Issue:8 Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Clinical Trials, Phase II as Topic; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Humans; Nitriles; Pyridines; Triazoles	2006
Antifungal efficacy and pharmacodynamics of posaconazole in experimental models of invasive fungal infections. Mycoses, 2006, Volume: 49 Suppl 1 Topics: Animals; Antifungal Agents; Aspergillosis; Candidiasis; Disease Models, Animal; Humans; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Mycoses; Rabbits; Rats; Treatment Outcome; Triazoles	2006
New agents for the treatment of fungal infections: clinical efficacy and gaps in coverage. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Oct-15, Volume: 43, Issue:8 Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Clinical Trials as Topic; Cryptococcosis; Echinocandins; Fever; Humans; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Neutropenia; Peptides, Cyclic; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole	2006
Recent advances in antifungal chemotherapy. International journal of antimicrobial agents, 2007, Volume: 30, Issue:2 Topics: Antifungal Agents; Aspergillosis; Candidiasis; Double-Blind Method; Drug Resistance, Fungal; Drug Therapy, Combination; Humans; Multicenter Studies as Topic; Mycoses; Peptides, Cyclic; Randomized Controlled Trials as Topic; Triazoles	2007
Pharmacodynamic implications for use of antifungal agents. Current opinion in pharmacology, 2007, Volume: 7, Issue:5 Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Echinocandins; Flucytosine; Humans; Microbial Sensitivity Tests; Polyenes; Triazoles	2007
[The role of voriconazole in the treatment of emerging mycoses]. Revista iberoamericana de micologia, 2007, Sep-30, Volume: 24, Issue:3 Topics: Antifungal Agents; Aspergillosis; Candidiasis; Communicable Diseases, Emerging; Fusarium; Humans; Mycoses; Opportunistic Infections; Paecilomyces; Pyrimidines; Scedosporium; Triazoles; Voriconazole	2007
Posaconazole: an extended-spectrum triazole antifungal agent. Clinical therapeutics, 2007, Volume: 29, Issue:9 Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Antifungal Agents; Aspergillosis; Candidiasis; Drug Resistance, Fungal; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Tissue Distribution; Triazoles	2007
Candida endophthalmitis: focus on current and future antifungal treatment options. Pharmacotherapy, 2007, Volume: 27, Issue:12 Topics: Amphotericin B; Antifungal Agents; Candidiasis; Echinocandins; Endophthalmitis; Fluconazole; Flucytosine; Humans; Pyrimidines; Risk Factors; Triazoles; Voriconazole	2007
Reviews of anti-infective agents: posaconazole: a broad-spectrum triazole antifungal agent. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Dec-15, Volume: 45, Issue:12 Topics: Animals; Antifungal Agents; Candidiasis; Controlled Clinical Trials as Topic; Disease Models, Animal; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Triazoles	2007
Fungicidal versus Fungistatic: what's in a word? Expert opinion on pharmacotherapy, 2008, Volume: 9, Issue:6 Topics: Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Clinical Trials as Topic; Cryptococcosis; Cryptococcus; Echinocandins; Humans; Meningitis, Cryptococcal; Microbiological Techniques; Polyenes; Triazoles	2008
Posaconazole : a review of its use in the prophylaxis of invasive fungal infections. Drugs, 2008, Volume: 68, Issue:7 Topics: Antifungal Agents; Aspergillosis; Candidiasis; Cost-Benefit Analysis; Drug Interactions; Drug Resistance, Fungal; Humans; In Vitro Techniques; Triazoles	2008
Antifungal prophylaxis in patients with hematologic malignancies: a reappraisal. Blood, 1995, Sep-15, Volume: 86, Issue:6 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Candidiasis; Clinical Trials as Topic; Disease Susceptibility; Drug Administration Routes; Hematopoietic Cell Growth Factors; Humans; Immunocompromised Host; Leukocyte Transfusion; Mycoses; Neoplasms; Neutropenia; Triazoles	1995
Worsening of liver function with fluconazole and review of azole antifungal hepatotoxicity. The Annals of pharmacotherapy, 1994, Volume: 28, Issue:10 Topics: Administration, Oral; Alanine Transaminase; Aspartate Aminotransferases; Candidiasis; Chemical and Drug Induced Liver Injury; Female; Fluconazole; Hospitals, Teaching; Humans; Liver Diseases; Liver Function Tests; Middle Aged; Triazoles; Urinary Tract Infections	1994
Prevention of invasive fungal infections in patients with neoplastic disease. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1993, Volume: 17 Suppl 2 Topics: Amphotericin B; Aspergillosis; Candidiasis; Cytokines; Drug Administration Routes; Humans; Imidazoles; Neoplasms; Opportunistic Infections; Polyenes; Triazoles	1993
[Fungal infections in patients undergoing solid organ transplantation]. Enfermedades infecciosas y microbiologia clinica, 1997, Volume: 15 Suppl 2 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Celiac Artery; Cytomegalovirus Infections; Female; Heart Transplantation; Humans; Immunocompromised Host; Immunosuppression Therapy; Incidence; Liver Transplantation; Male; Middle Aged; Mucormycosis; Mycoses; Postoperative Complications; Risk Factors; Thrombosis; Time Factors; Transplantation; Triazoles	1997
Role of newer azoles in surgical patients. Journal of chemotherapy (Florence, Italy), 1999, Volume: 11, Issue:6 Topics: Antifungal Agents; Azoles; Candidiasis; Cross Infection; Dose-Response Relationship, Drug; Drug Design; Fluconazole; Humans; Pyrimidines; Surgical Wound Infection; Triazoles; Voriconazole	1999
Novel triazole antifungal agents. Expert opinion on investigational drugs, 2000, Volume: 9, Issue:3 Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Humans; Immunocompromised Host; Mycoses; Opportunistic Infections; Triazoles	2000
[Invasive fungal infections. Epidemiology and new therapies]. Presse medicale (Paris, France : 1983), 2000, Dec-02, Volume: 29, Issue:37 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Drug Resistance, Microbial; Humans; Immunocompromised Host; Incidence; Nystatin; Risk Factors; Triazoles	2000
Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. The Lancet. Infectious diseases, 2002, Volume: 2, Issue:2 Topics: Amphotericin B; Antifungal Agents; Azoles; Candida; Candidiasis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Flucytosine; Fungemia; Humans; Microbial Sensitivity Tests; Oxidoreductases; Sterol 14-Demethylase; Triazoles	2002
Voriconazole -- better chances for patients with invasive mycoses. European journal of medical research, 2002, May-31, Volume: 7, Issue:5 Topics: Antifungal Agents; Candida; Candidiasis; Drug Interactions; Drug Resistance, Fungal; Drug Tolerance; Humans; Mycoses; Pyrimidines; Safety; Triazoles; Voriconazole	2002

Trials

15 trial(s) available for triazoles and Candidiasis

Article	Year
Use of Novasomes as a Vesicular Carrier for Improving the Topical Delivery of Terconazole: In Vitro Characterization, In Vivo Assessment and Exploratory Clinical Experimentation. International journal of nanomedicine, 2021, Volume: 16 Topics: Administration, Topical; Animals; Antifungal Agents; Candida albicans; Candidiasis; Drug Carriers; Drug Delivery Systems; Factor Analysis, Statistical; Humans; Infant; Liposomes; Male; Microbial Sensitivity Tests; Particle Size; Rats; Rats, Wistar; Skin; Skin Absorption; Static Electricity; Suspensions; Triazoles	2021
Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes on background metformin and pioglitazone. Diabetes, obesity & metabolism, 2014, Volume: 16, Issue:5 Topics: Blood Glucose; Blood Pressure; Canagliflozin; Candidiasis; Diabetes Mellitus, Type 2; Diuretics, Osmotic; Double-Blind Method; Drug Therapy, Combination; Female; Genital Diseases, Female; Genital Diseases, Male; Glucosides; Humans; Hypoglycemic Agents; Lipids; Male; Metformin; Middle Aged; Pioglitazone; Pyrazines; Sitagliptin Phosphate; Thiazolidinediones; Thiophenes; Treatment Outcome; Triazoles; Weight Loss	2014
A phase 2, randomized, double-blind, multicenter trial to evaluate the safety and efficacy of three dosing regimens of isavuconazole compared with fluconazole in patients with uncomplicated esophageal candidiasis. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:3 Topics: Administration, Oral; Adult; Antifungal Agents; Candidiasis; Double-Blind Method; Esophageal Diseases; Female; Fluconazole; Humans; Male; Nitriles; Pyridines; Triazoles	2015
Impact of antifungal prophylaxis on colonization and azole susceptibility of Candida species. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12 Topics: Adolescent; Adult; Aged; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candidiasis; Female; Fluconazole; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Phylogeny; Triazoles; Young Adult	2009
Voriconazole treatment for less-common, emerging, or refractory fungal infections. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003, May-01, Volume: 36, Issue:9 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Candidiasis; Child; Humans; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole	2003
Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints. Journal of clinical microbiology, 2006, Volume: 44, Issue:3 Topics: Antifungal Agents; Candida; Candidiasis; Data Interpretation, Statistical; Drug Resistance, Fungal; Endpoint Determination; Fluconazole; Humans; Inhibitory Concentration 50; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2006
A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Apr-15, Volume: 42, Issue:8 Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis; Candidiasis, Oral; Double-Blind Method; Ethnicity; Female; Fluconazole; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pharyngeal Diseases; Probability; Treatment Outcome; Triazoles	2006
Variability of voriconazole plasma levels measured by new high-performance liquid chromatography and bioassay methods. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:1 Topics: Adult; Antifungal Agents; Area Under Curve; Biological Assay; Candida albicans; Candidiasis; Chromatography, High Pressure Liquid; Female; Humans; Male; Metabolic Clearance Rate; Microbial Sensitivity Tests; Middle Aged; Mutation; Pyrimidines; Reproducibility of Results; Spectrophotometry, Ultraviolet; Treatment Outcome; Triazoles; Voriconazole	2007
Posaconazole for the treatment of azole-refractory oropharyngeal and esophageal candidiasis in subjects with HIV infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Feb-15, Volume: 44, Issue:4 Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Candidiasis; Candidiasis, Oral; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Fungal; Esophageal Diseases; Female; Fluconazole; Follow-Up Studies; Humans; Itraconazole; Male; Middle Aged; Probability; Severity of Illness Index; Treatment Failure; Treatment Outcome; Triazoles	2007
A dose comparison study of a new triazole antifungal (D0870) in HIV-positive patients with oral candidiasis. AIDS (London, England), 1997, Volume: 11, Issue:6 Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candida albicans; Candidiasis; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mouth Diseases; Recurrence; Treatment Outcome; Triazoles	1997
A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2001, Nov-01, Volume: 33, Issue:9 Topics: Adolescent; Adult; Aged; Antifungal Agents; Candidiasis; Consumer Product Safety; Double-Blind Method; Esophageal Diseases; Female; Fluconazole; Humans; Immunocompromised Host; Male; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole	2001
[Clinical study of fluconazole on deep-seated fungal infections]. The Japanese journal of antibiotics, 1989, Volume: 42, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Candidiasis; Child; Clinical Trials as Topic; Cryptococcosis; Drug Tolerance; Female; Fluconazole; Humans; Japan; Male; Middle Aged; Multicenter Studies as Topic; Mycoses; Triazoles	1989
Clinical evaluation of terconazole. European experience. The Journal of reproductive medicine, 1989, Volume: 34, Issue:8 Suppl Topics: Administration, Topical; Antifungal Agents; Candidiasis; Clinical Trials as Topic; Clotrimazole; Europe; Female; Formularies as Topic; Humans; Miconazole; Multicenter Studies as Topic; Suppositories; Triazoles; Vaginal Creams, Foams, and Jellies; Vulvovaginitis	1989
Clinical evaluation of terconazole. United states experience. The Journal of reproductive medicine, 1989, Volume: 34, Issue:8 Suppl Topics: Antifungal Agents; Candidiasis; Consumer Product Safety; Female; Humans; Multicenter Studies as Topic; Random Allocation; Suppositories; Triazoles; United States; Vulvovaginitis	1989
Fluconazole in the management of patients with chronic mucocutaneous candidosis. The British journal of dermatology, 1988, Volume: 119, Issue:5 Topics: Adolescent; Adult; Antifungal Agents; Candidiasis; Candidiasis, Chronic Mucocutaneous; Clinical Trials as Topic; Fluconazole; Humans; Triazoles	1988

Other Studies

331 other study(ies) available for triazoles and Candidiasis

Article	Year
MK-5204: An orally active β-1,3-glucan synthesis inhibitor. Bioorganic & medicinal chemistry letters, 2020, 09-01, Volume: 30, Issue:17 Topics: Administration, Oral; Animals; Antifungal Agents; beta-Glucans; Candida; Candidiasis; Disease Models, Animal; Glucosyltransferases; Glycosides; Half-Life; Mice; Microbial Sensitivity Tests; Stereoisomerism; Structure-Activity Relationship; Triazoles; Triterpenes	2020
Triazole Evolution of Candida parapsilosis Results in Cross-Resistance to Other Antifungal Drugs, Influences Stress Responses, and Alters Virulence in an Antifungal Drug-Dependent Manner. mSphere, 2020, 10-28, Volume: 5, Issue:5 Topics: Animals; Antifungal Agents; Candida parapsilosis; Candidiasis; Drug Resistance, Fungal; Evolution, Molecular; Female; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Stress, Physiological; Triazoles	2020
In vitro synergy of isavuconazole in combination with colistin against Candida auris. Scientific reports, 2020, 12-08, Volume: 10, Issue:1 Topics: Agar; Antifungal Agents; Candida; Candidiasis; Colistin; Colony Count, Microbial; Drug Synergism; Humans; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles	2020
In Vitro activity of ravuconazole against Candida auris and vaginal candida isolates. Mycoses, 2021, Volume: 64, Issue:6 Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Female; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Thiazoles; Triazoles; Vagina	2021
Selective BET bromodomain inhibition as an antifungal therapeutic strategy. Nature communications, 2017, 05-18, Volume: 8 Topics: Amino Acid Sequence; Animals; Antifungal Agents; Azabicyclo Compounds; Azepines; Benzodiazepines; Binding Sites; Candida albicans; Candidiasis; Crystallography, X-Ray; Fungal Proteins; Gene Expression; Humans; Mice; Models, Molecular; Molecular Targeted Therapy; Protein Binding; Protein Interaction Domains and Motifs; Protein Structure, Secondary; Pyridines; Recombinant Proteins; Sequence Alignment; Sequence Homology, Amino Acid; Species Specificity; Transcription Factors; Triazoles	2017
The synthesis, antifungal and apoptotic effects of triazole-oxadiazoles against Candida species. European journal of medicinal chemistry, 2018, Jan-20, Volume: 144 Topics: Antifungal Agents; Candida; Candidiasis; Humans; Microbial Sensitivity Tests; Oxadiazoles; Structure-Activity Relationship; Triazoles	2018
Candida infanticola and Candida spencermartinsiae yeasts: Possible emerging species in cancer patients. Microbial pathogenesis, 2018, Volume: 115 Topics: Adolescent; Antifungal Agents; Candida; Candidiasis; Caspofungin; Child, Preschool; Echinocandins; Fluconazole; Humans; Kluyveromyces; Lipopeptides; Male; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Nitriles; Opportunistic Infections; Pichia; Pyridines; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Triazoles; Voriconazole	2018
Photodynamic Inactivation Potentiates the Susceptibility of Antifungal Agents against the Planktonic and Biofilm Cells of Candida albicans. International journal of molecular sciences, 2018, Feb-01, Volume: 19, Issue:2 Topics: Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Fluconazole; Humans; Light; Microbial Sensitivity Tests; Photochemotherapy; Plankton; Tolonium Chloride; Triazoles	2018
First report of sporadic cases of Candida auris in Colombia. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2018, Volume: 69 Topics: Aged; Antifungal Agents; Candida; Candida albicans; Candidiasis; Colombia; Disease Outbreaks; Drug Resistance, Multiple, Fungal; Female; Humans; Infection Control; Male; Microbial Sensitivity Tests; Middle Aged; Phenotype; Sequence Analysis, DNA; Triazoles	2018
Anti-candidal activity of selected analgesic drugs used alone and in combination with fluconazole, itraconazole, voriconazole, posaconazole and isavuconazole. Journal de mycologie medicale, 2018, Volume: 28, Issue:2 Topics: Acetaminophen; Analgesics; Antifungal Agents; Aspirin; Candida; Candida albicans; Candida glabrata; Candidiasis; Dipyrone; Drug Resistance, Fungal; Fluconazole; Humans; Ibuprofen; Itraconazole; Meloxicam; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles; Voriconazole	2018
Candida auris Sternal Osteomyelitis in a Man from Kenya Visiting Australia, 2015. Emerging infectious diseases, 2019, Volume: 25, Issue:1 Topics: Aged; Antifungal Agents; Australia; Bone and Bones; Candida; Candidiasis; Chronic Disease; Fatal Outcome; Humans; Kenya; Male; Osteomyelitis; Tomography, X-Ray Computed; Travel; Triazoles; Whole Genome Sequencing	2019
Abrogation of Triazole Resistance upon Deletion of Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:4 Topics: Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Candida; Candidiasis; CRISPR-Associated Protein 9; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Gene Deletion; Gene Expression Regulation, Fungal; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Microorganisms, Genetically-Modified; Triazoles	2019
Cis-2-dodecenoic Acid Mediates Its Synergistic Effect with Triazoles by Interfering with Efflux Pumps in Fluconazole-resistant Candida albicans. Biomedical and environmental sciences : BES, 2019, Volume: 32, Issue:3 Topics: Antifungal Agents; Burkholderia cenocepacia; Candida albicans; Candidiasis; Drug Resistance, Fungal; Fatty Acids, Monounsaturated; Fluconazole; Humans; Microbial Sensitivity Tests; Triazoles	2019
In vitro antifungal activity of a novel topical triazole PC945 against emerging yeast Candida auris. The Journal of antimicrobial chemotherapy, 2019, 10-01, Volume: 74, Issue:10 Topics: Antifungal Agents; Asia; Benzamides; Candida; Candida parapsilosis; Candidiasis; Humans; Microbial Sensitivity Tests; Tertiary Care Centers; Triazoles; United Kingdom; United States	2019
Native aortic valve fungal endocarditis. BMJ case reports, 2013, Feb-20, Volume: 2013 Topics: Administration, Oral; Adult; Antifungal Agents; Aortic Valve; Candida albicans; Candidiasis; Diagnosis, Differential; Echocardiography, Transesophageal; Endocarditis; Follow-Up Studies; Heart Valve Diseases; Humans; Male; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole	2013
Voriconazole therapeutic drug monitoring: retrospective cohort study of the relationship to clinical outcomes and adverse events. BMC infectious diseases, 2013, Feb-26, Volume: 13 Topics: Adult; Antifungal Agents; Brain Diseases, Metabolic; Candidiasis; Drug Administration Schedule; Drug Monitoring; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Liver; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole	2013
Posaconazole exhibits in vitro and in vivo synergistic antifungal activity with caspofungin or FK506 against Candida albicans. PloS one, 2013, Volume: 8, Issue:3 Topics: Animals; Antifungal Agents; Base Sequence; Candida albicans; Candidiasis; Caspofungin; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Ergosterol; Lipopeptides; Male; Mice; Molecular Sequence Data; Mutation; Sequence Homology, Nucleic Acid; Tacrolimus; Triazoles	2013
Antifungal efficacy during Candida krusei infection in non-conventional models correlates with the yeast in vitro susceptibility profile. PloS one, 2013, Volume: 8, Issue:3 Topics: Amphotericin B; Animals; Antifungal Agents; Caenorhabditis elegans; Candida; Candidiasis; Fluconazole; Lepidoptera; Pyrimidines; Triazoles; Voriconazole	2013
Candida krusei arthritis in an adolescent with acute myelogenous leukemia. The Pediatric infectious disease journal, 2013, Volume: 32, Issue:10 Topics: Adolescent; Antifungal Agents; Arthritis, Infectious; Candida; Candidiasis; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Pyrimidines; Triazoles; Voriconazole	2013
Molecular mechanisms of drug resistance in clinical Candida species isolated from Tunisian hospitals. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:7 Topics: Amino Acid Sequence; Amino Acid Substitution; Amphotericin B; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azoles; Base Sequence; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Ergosterol; Fluconazole; Fungal Proteins; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Polyenes; Pyrimidines; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Sequence Analysis, DNA; Triazoles; Tunisia; Voriconazole	2013
In vitro fluconazole and voriconazole susceptibilities of Candida bloodstream isolates in Korea: use of the CLSI and EUCAST epidemiological cutoff values. Annals of laboratory medicine, 2013, Volume: 33, Issue:3 Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Republic of Korea; Triazoles; Voriconazole	2013
In vitro activities of isavuconazole and comparator antifungal agents tested against a global collection of opportunistic yeasts and molds. Journal of clinical microbiology, 2013, Volume: 51, Issue:8 Topics: Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Humans; Microbial Sensitivity Tests; Nitriles; Opportunistic Infections; Pyridines; Triazoles	2013
Candida urinary tract infection and Candida species susceptibilities to antifungal agents. The Journal of antibiotics, 2013, Volume: 66, Issue:11 Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis; Female; Fluconazole; Flucytosine; Hospitals, University; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Pyrimidines; Retrospective Studies; Risk Factors; Triazoles; Urinary Tract Infections; Voriconazole	2013
Isavuconazole pharmacodynamic target determination for Candida species in an in vivo murine disseminated candidiasis model. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:11 Topics: Animals; Antifungal Agents; Area Under Curve; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Half-Life; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Nitriles; Pyridines; Species Specificity; Triazoles	2013
Interaction between caspofungin or voriconazole and cefoperazone-sulbactam or piperacillin-tazobactam by in vitro and in vivo methods. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 2014, Volume: 122, Issue:5 Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Candida albicans; Candidiasis; Caspofungin; Cefoperazone; Drug Interactions; Echinocandins; Female; Lipopeptides; Mice; Mice, Inbred BALB C; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pyrimidines; Sulbactam; Triazoles; Voriconazole	2014
Predictors of invasive fungal infection in pediatric allogeneic hematopoietic SCT recipients. Bone marrow transplantation, 2014, Volume: 49, Issue:1 Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Child; Child, Preschool; Echinocandins; Female; Fusariosis; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Lipopeptides; Logistic Models; Male; Mycoses; Neutrophils; Prospective Studies; Pyrimidines; Retrospective Studies; Risk; Treatment Outcome; Triazoles; Voriconazole; Young Adult	2014
Molecular identification and antifungal susceptibility of yeast isolates causing fungemia collected in a population-based study in Spain in 2010 and 2011. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:3 Topics: Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Drug Resistance, Fungal; Echinocandins; Fungemia; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Spain; Triazoles; Voriconazole	2014
Efficacy and safety of antifungal additives in Optisol-GS corneal storage medium. JAMA ophthalmology, 2014, Volume: 132, Issue:7 Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candida glabrata; Candidiasis; Cell Count; Chondroitin Sulfates; Colony Count, Microbial; Complex Mixtures; Cornea; Culture Media, Serum-Free; Dextrans; Drug Combinations; Drug Contamination; Endothelium, Corneal; Gentamicins; Humans; Microbial Sensitivity Tests; Organ Preservation; Organ Preservation Solutions; Pyrimidines; Tissue Donors; Treatment Outcome; Triazoles; Voriconazole	2014
Isavuconazole and nine comparator antifungal susceptibility profiles for common and uncommon Candida species collected in 2012: application of new CLSI clinical breakpoints and epidemiological cutoff values. Mycopathologia, 2014, Volume: 178, Issue:1-2 Topics: Antifungal Agents; Candida; Candidiasis; DNA, Fungal; DNA, Ribosomal; DNA, Ribosomal Spacer; Global Health; Humans; Microbial Sensitivity Tests; Nitriles; Pyridines; RNA, Ribosomal, 28S; Sequence Analysis, DNA; Triazoles	2014
Primary antifungal prophylaxis with micafungin in patients with haematological malignancies: real-life data from a retrospective single-centre observational study. European journal of haematology, 2015, Volume: 94, Issue:3 Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Administration Schedule; Echinocandins; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Injections, Intravenous; Lipopeptides; Male; Micafungin; Middle Aged; Retrospective Studies; Transplantation, Homologous; Triazoles; Trichosporon; Trichosporonosis	2015
Synthesis and antimicrobial evaluation of 5-aryl-1,2,4-triazole-3-thione derivatives containing a rhodanine moiety. Bioorganic & medicinal chemistry letters, 2015, Aug-01, Volume: 25, Issue:15 Topics: Anti-Infective Agents; Candida albicans; Candidiasis; Escherichia coli; Escherichia coli Infections; Humans; Rhodanine; Staphylococcal Infections; Staphylococcus aureus; Thiones; Triazoles	2015
Voriconazole and posaconazole therapy for experimental Candida lusitaniae infection. Diagnostic microbiology and infectious disease, 2016, Volume: 84, Issue:1 Topics: Animals; Antifungal Agents; beta-Glucans; Candida; Candidiasis; Colony Count, Microbial; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Kidney; Male; Mice; Proteoglycans; Treatment Outcome; Triazoles; Voriconazole	2016
Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1 Topics: Alleles; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Candida albicans; Candida glabrata; Candidiasis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Gene Expression Regulation, Fungal; Humans; Itraconazole; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation; Nitriles; Protein Isoforms; Pyridines; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Triazoles; Voriconazole	2016
Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey. Annals of clinical microbiology and antimicrobials, 2016, May-31, Volume: 15, Issue:1 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Humans; Lipopeptides; Microbial Sensitivity Tests; Species Specificity; Triazoles; Voriconazole	2016
Cell wall composition and biofilm formation of azoles-susceptible and -resistant Candida glabrata strains. Journal of chemotherapy (Florence, Italy), 2017, Volume: 29, Issue:3 Topics: Adhesiveness; Antifungal Agents; Azoles; Biofilms; Candida glabrata; Candidiasis; Carbohydrate Metabolism; Cell Wall; Drug Resistance, Multiple, Fungal; Fungal Polysaccharides; Fungal Proteins; Gene Expression Regulation, Fungal; Hydrophobic and Hydrophilic Interactions; Microbial Sensitivity Tests; Mutation; Proteomics; Species Specificity; Surface Properties; Triazoles; Two-Dimensional Difference Gel Electrophoresis	2017
Identification of novel antifungal lead compounds through pharmacophore modeling, virtual screening, molecular docking, antimicrobial evaluation, and gastrointestinal permeation studies. Journal of biomolecular structure & dynamics, 2017, Volume: 35, Issue:11 Topics: 14-alpha Demethylase Inhibitors; Antifungal Agents; Aspergillosis; Aspergillus niger; Candida; Candidiasis; Gastrointestinal Tract; Humans; Ligands; Microbial Sensitivity Tests; Models, Molecular; Molecular Docking Simulation; Permeability; Triazoles	2017
Use of phylogenetical analysis to predict susceptibility of pathogenic Candida spp. to antifungal drugs. Journal of microbiological methods, 2016, Volume: 131 Topics: Antifungal Agents; Base Sequence; Biological Evolution; Candida; Candidiasis; Databases, Nucleic Acid; DNA, Fungal; Echinocandins; Genes, Essential; Genes, Fungal; Microbial Sensitivity Tests; Multigene Family; Phylogeny; Polyenes; Triazoles	2016
Effect of novel triazole-amino acid hybrids on growth and virulence of Candida species: in vitro and in vivo studies. Organic & biomolecular chemistry, 2016, Dec-07, Volume: 14, Issue:45 Topics: Amino Acids; Antifungal Agents; Candida; Candidiasis; Fluconazole; HEK293 Cells; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Sterol 14-Demethylase; Triazoles; Virulence	2016
Synergistic Effects of Tetrandrine with Posaconazole Against Aspergillus fumigatus. Microbial drug resistance (Larchmont, N.Y.), 2017, Volume: 23, Issue:6 Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Benzylisoquinolines; Candidiasis; Drug Resistance, Fungal; Drug Synergism; Female; Humans; Itraconazole; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Triazoles; Voriconazole	2017
Fatal Aspergillus fumigatus and Candida glabrata infections with posaconazole prophylaxis after stem cell transplantation. International journal of antimicrobial agents, 2008, Volume: 32, Issue:4 Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candida glabrata; Candidiasis; Chemoprevention; Fatal Outcome; Humans; Male; Middle Aged; Stem Cell Transplantation; Triazoles	2008
Trends in species distribution and susceptibility of bloodstream isolates of Candida collected in Monterrey, Mexico, to seven antifungal agents: results of a 3-year (2004 to 2007) surveillance study. Journal of clinical microbiology, 2008, Volume: 46, Issue:9 Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Caspofungin; Child; Child, Preschool; Echinocandins; Female; Fluconazole; Humans; Infant; Infant, Newborn; Itraconazole; Lipopeptides; Male; Mexico; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Thiazoles; Triazoles; Voriconazole; Young Adult	2008
Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains. Medical mycology, 2009, Volume: 47, Issue:2 Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Azoles; Candida; Candida albicans; Candidiasis; Child; Child, Preschool; Drug Resistance, Fungal; Female; Fluconazole; Humans; Infant; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance; Pyrimidines; Triazoles; Venezuela; Voriconazole; Young Adult	2009
Comparison of posaconazole and voriconazole in vitro killing against Candida krusei. Diagnostic microbiology and infectious disease, 2008, Volume: 62, Issue:2 Topics: Antifungal Agents; Candida; Candidiasis; Culture Media; Drug Resistance, Fungal; Fungemia; Humans; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole	2008
Posaconazole in intensive care patients I: invasive fungal infections in surgical intensive care and case presentation. Mycoses, 2008, Volume: 51 Suppl 2 Topics: Aged; Antifungal Agents; Aspergillosis; Candidiasis; Critical Care; Cross Infection; Humans; Middle Aged; Mycoses; Postoperative Complications; Triazoles	2008
Breakthrough invasive fungal infection in an immunocompromised host while on posaconazole prophylaxis: an omission in patient counseling and follow-up. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2008, Volume: 14, Issue:4 Topics: Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Candidiasis; Female; Humans; Immunosuppression Therapy; Leukemia, Myeloid, Acute; Middle Aged; Mucormycosis; Paranasal Sinus Diseases; Patient Compliance; Patient Education as Topic; Triazoles	2008
Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies. International journal of antimicrobial agents, 2008, Volume: 32, Issue:6 Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Clinical Trials, Phase III as Topic; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole; Yeasts	2008
Voriconazole-induced photosensitivity. Clinical medicine & research, 2008, Volume: 6, Issue:2 Topics: Antifungal Agents; Candidiasis; Endocarditis; Humans; Male; Middle Aged; Photosensitivity Disorders; Pyrimidines; Triazoles; Voriconazole	2008
Posaconazole as salvage therapy in patients with invasive fungal infections after solid organ transplant. Transplantation, 2008, Sep-27, Volume: 86, Issue:6 Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Candidiasis; Female; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Mycoses; Organ Transplantation; Postoperative Complications; Retrospective Studies; Safety; Treatment Outcome; Triazoles	2008
National surveillance of antifungal susceptibility of Candida species in South Korean hospitals. Medical mycology, 2009, Volume: 47, Issue:5 Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucytosine; Hospitals; Humans; Microbial Sensitivity Tests; Population Surveillance; Pyrimidines; Republic of Korea; Triazoles; Voriconazole	2009
Efficacy of isavuconazole, voriconazole and fluconazole in temporarily neutropenic murine models of disseminated Candida tropicalis and Candida krusei. The Journal of antimicrobial chemotherapy, 2009, Volume: 63, Issue:1 Topics: Animals; Antifungal Agents; Brain; Candidiasis; Colony Count, Microbial; Dose-Response Relationship, Drug; Fluconazole; Kidney; Male; Mice; Neutropenia; Nitriles; Pyridines; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole	2009
Free renal levels of voriconazole determined by microdialysis in healthy and Candida sp.-infected Wistar rats. International journal of antimicrobial agents, 2009, Volume: 33, Issue:2 Topics: Animals; Antifungal Agents; Area Under Curve; Candidiasis; Kidney; Male; Microdialysis; Models, Animal; Protein Binding; Pyrimidines; Rats; Rats, Wistar; Serum; Triazoles; Voriconazole	2009
A global evaluation of voriconazole activity tested against recent clinical isolates of Candida spp. Diagnostic microbiology and infectious disease, 2009, Volume: 63, Issue:2 Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Global Health; Humans; Microbial Sensitivity Tests; Population Surveillance; Pyrimidines; Triazoles; Voriconazole	2009
Synthesis and antifungal activity of 1,2,3-triazole containing fluconazole analogues. Bioorganic & medicinal chemistry letters, 2009, Feb-01, Volume: 19, Issue:3 Topics: Animals; Antifungal Agents; Bile Acids and Salts; Candida albicans; Candidiasis; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Design; Drug Screening Assays, Antitumor; Fluconazole; Humans; Inhibitory Concentration 50; Mice; Models, Chemical; Triazoles	2009
Susceptibility to voriconazole, fluconazole, and ketoconazole of yeast isolated from patients with hematological malignancies. Journal of chemotherapy (Florence, Italy), 2008, Volume: 20, Issue:6 Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Hematologic Neoplasms; Humans; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2008
Triazole-resistant candidaemia following posaconazole exposure. International journal of antimicrobial agents, 2009, Volume: 33, Issue:5 Topics: Adult; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Female; Fungemia; Humans; Male; Microbial Sensitivity Tests; Triazoles; Young Adult	2009
In vitro activity of caspofungin and voriconazole against uncommon Candida spp. International journal of antimicrobial agents, 2009, Volume: 33, Issue:6 Topics: Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2009
Recent experience with fungaemia: change in species distribution and azole resistance. Scandinavian journal of infectious diseases, 2009, Volume: 41, Issue:4 Topics: Adult; Antifungal Agents; Candida; Candidiasis; Child; Drug Resistance, Fungal; Fungemia; Humans; India; Risk Factors; Treatment Outcome; Triazoles	2009
Candida parapsilosis endocarditis in aged patient. European journal of internal medicine, 2009, Volume: 20, Issue:1 Topics: Aged, 80 and over; Antifungal Agents; Candida; Candidiasis; Drug Therapy, Combination; Endocarditis; Female; Fluconazole; Humans; Pyrimidines; Triazoles; Voriconazole	2009
In vitro antifungal combination effects of micafungin with fluconazole, voriconazole, amphotericin B, and flucytosine against clinical isolates of Candida species. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2009, Volume: 15, Issue:1 Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Synergism; Echinocandins; Fluconazole; Flucytosine; Humans; Lipopeptides; Micafungin; Pyrimidines; Triazoles; Voriconazole	2009
Breakthrough Candida dubliniensis fungemia in an acute myeloid leukemia patient during voriconazole therapy successfully treated with caspofungin. Journal of chemotherapy (Florence, Italy), 2009, Volume: 21, Issue:1 Topics: Adult; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Candida; Candidiasis; Caspofungin; Catheter-Related Infections; Cross Infection; Echinocandins; Fungemia; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Male; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole	2009
Topical and oral voriconazole in the treatment of fungal keratitis. Korean journal of ophthalmology : KJO, 2009, Volume: 23, Issue:1 Topics: Administration, Oral; Antifungal Agents; Candidiasis; Cornea; Diagnosis, Differential; Dose-Response Relationship, Drug; Eye Infections, Fungal; Follow-Up Studies; Humans; Keratitis; Male; Middle Aged; Ophthalmic Solutions; Pyrimidines; Triazoles; Voriconazole	2009
Pharmacokinetic/pharmacodynamic modelling and in vitro simulation of dynamic voriconazole-Candida interactions. International journal of antimicrobial agents, 2009, Volume: 34, Issue:3 Topics: Administration, Oral; Algorithms; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candidiasis; Humans; Infusions, Intravenous; Microbial Sensitivity Tests; Models, Theoretical; Pyrimidines; Time Factors; Triazoles; Voriconazole	2009
[Two cases of mycoses associated with hematologic disease]. The Japanese journal of antibiotics, 2008, Volume: 61, Issue:5 Topics: Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Cunninghamella; Fatal Outcome; Humans; Liposomes; Male; Mucormycosis; Myelodysplastic Syndromes; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole	2008
Safe management of tacrolimus together with posaconazole in lung transplant patients with cystic fibrosis. Therapeutic drug monitoring, 2009, Volume: 31, Issue:3 Topics: Adult; Antifungal Agents; Aspergillosis; Candidiasis; Cystic Fibrosis; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Enzyme Inhibitors; Female; Graft Rejection; Humans; Immunosuppressive Agents; Itraconazole; Lung Transplantation; Male; Microbial Sensitivity Tests; Mycoses; Prescriptions; Pyrimidines; Tacrolimus; Triazoles; Voriconazole	2009
[In vitro activity of voriconazole and other antifungal agents against clinical isolates of 138 Candida spp]. Le infezioni in medicina, 2009, Volume: 17, Issue:1 Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Species Specificity; Triazoles; Voriconazole	2009
Reliability of the Vitek 2 yeast susceptibility test for detection of in vitro resistance to fluconazole and voriconazole in clinical isolates of Candida albicans and Candida glabrata. Journal of clinical microbiology, 2009, Volume: 47, Issue:6 Topics: Antifungal Agents; Candida albicans; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Sensitivity and Specificity; Triazoles; Voriconazole	2009
[Conservative management with new antifungals in a case of Candida prosthetic valve endocarditis]. Enfermedades infecciosas y microbiologia clinica, 2010, Volume: 28, Issue:1 Topics: Amphotericin B; Antifungal Agents; Bioprosthesis; Candidiasis; Caspofungin; Drug Therapy, Combination; Echinocandins; Endocarditis; Heart Valve Prosthesis; Humans; Lipopeptides; Liposomes; Male; Middle Aged; Photosensitivity Disorders; Postoperative Complications; Prosthesis-Related Infections; Pyrimidines; Triazoles; Voriconazole	2010
Pharmacokinetics and pharmacodynamics of a novel triazole, isavuconazole: mathematical modeling, importance of tissue concentrations, and impact of immune status on antifungal effect. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:8 Topics: Animals; Antifungal Agents; Candidiasis; Kidney; Male; Mice; Models, Theoretical; Nitriles; Proportional Hazards Models; Pyridines; Triazoles	2009
In vitro activities of fluconazole, itraconazole and voriconazole against otomycotic fungal pathogens. The Journal of laryngology and otology, 2009, Volume: 123, Issue:9 Topics: Antifungal Agents; Aspergillus; Candida albicans; Candidiasis; Colony Count, Microbial; Ear Diseases; Fluconazole; Humans; Itraconazole; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole	2009
Synthesis, cleavage, and antifungal activity of a number of novel, water-soluble ester prodrugs of antifungal triazole CS-758. Bioorganic & medicinal chemistry letters, 2009, Jul-01, Volume: 19, Issue:13 Topics: Animals; Antifungal Agents; Candidiasis; Humans; Mice; Microsomes, Liver; Prodrugs; Rats; Triazoles; Water	2009
Efficacy of triazoles in a murine disseminated infection by Candida krusei. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:8 Topics: Amphotericin B; Animals; Antifungal Agents; Candida; Candidiasis; Kidney; Male; Mice; Pyrimidines; Random Allocation; Triazoles; Voriconazole	2009
Infections caused by Candida krusei in five transplant and two surgical patients. Surgical infections, 2009, Volume: 10, Issue:3 Topics: Adult; Aged; Antifungal Agents; Candida; Candidiasis; Caspofungin; Cluster Analysis; Cross Infection; DNA Fingerprinting; DNA, Fungal; Echinocandins; Female; Genotype; Humans; Immunocompromised Host; Lipopeptides; Male; Middle Aged; Mycological Typing Techniques; Organ Transplantation; Postoperative Complications; Pyrimidines; Random Amplified Polymorphic DNA Technique; Treatment Outcome; Triazoles; Voriconazole	2009
Chemical genetic profiling and characterization of small-molecule compounds that affect the biosynthesis of unsaturated fatty acids in Candida albicans. The Journal of biological chemistry, 2009, Jul-17, Volume: 284, Issue:29 Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Cerulenin; Cluster Analysis; Fatty Acid Desaturases; Fatty Acids, Unsaturated; Fungal Proteins; Gene Expression Profiling; Gene Expression Regulation, Fungal; Hyphae; Male; Mice; Mice, Inbred ICR; Molecular Structure; Mutation; Stearoyl-CoA Desaturase; Survival Rate; Thiazoles; Time Factors; Triazoles; Virulence	2009
Anidulafungin treatment of candidal central nervous system infection in a murine model. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:8 Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Candida albicans; Candidiasis; Central Nervous System Infections; Disease Models, Animal; Echinocandins; Female; Mice; Pyrimidines; Triazoles; Voriconazole	2009
Therapeutic efficacy of voriconazole against a fluconazole-resistant Candida albicans isolate in a vaginal model. The Journal of antimicrobial chemotherapy, 2009, Volume: 64, Issue:3 Topics: Administration, Intravaginal; Administration, Oral; Animals; Antifungal Agents; Candida albicans; Candidiasis; Colony Count, Microbial; Drug Resistance, Fungal; Female; Fluconazole; Mice; Mice, Inbred BALB C; Pyrimidines; Treatment Outcome; Triazoles; Vagina; Voriconazole	2009
Direct antifungal susceptibility testing of positive Candida blood cultures by sensititre YeastOne. The new microbiologica, 2009, Volume: 32, Issue:2 Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Reagent Kits, Diagnostic; Sensitivity and Specificity; Time Factors; Triazoles; Voriconazole	2009
Disk diffusion test and E-test with enriched Mueller-Hinton agar for determining susceptibility of Candida species to voriconazole and fluconazole. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2009, Volume: 42, Issue:2 Topics: Antifungal Agents; Candida; Candidiasis; Culture Media; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Taiwan; Triazoles; Voriconazole	2009
Effects of antifungal agents in sap activity of Candida albicans isolates. Mycopathologia, 2010, Volume: 169, Issue:2 Topics: Antifungal Agents; Aspartic Acid Proteases; Candida albicans; Candidiasis; Culture Media; DNA, Fungal; Drug Resistance, Fungal; Fluconazole; HIV Infections; Humans; Microbial Sensitivity Tests; Mouth Mucosa; Polymerase Chain Reaction; Pyrimidines; Triazoles; Voriconazole	2010
Prevalence rates and antifungal susceptibility profiles of the Candida parapsilosis species complex: results from a nationwide surveillance of candidaemia in Brazil. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2010, Volume: 16, Issue:7 Topics: Antifungal Agents; Brazil; Candida; Candidiasis; Caspofungin; DNA, Fungal; Drug Resistance, Fungal; Echinocandins; Flucytosine; Fungemia; Humans; Lipopeptides; Microbial Sensitivity Tests; Mycological Typing Techniques; Polyenes; Population Surveillance; Prevalence; Triazoles	2010
Voriconazole is safe and effective as prophylaxis for early and late fungal infections following allogeneic hematopoietic stem cell transplantation. Transplant infectious disease : an official journal of the Transplantation Society, 2010, Volume: 12, Issue:1 Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Candidiasis; Chemoprevention; Female; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Male; Middle Aged; Mycoses; Pyrimidines; Time Factors; Transplantation, Homologous; Triazoles; Voriconazole; Young Adult	2010
Therapeutic efficacy of posaconazole against Candida glabrata in a murine model of vaginitis. Mycoses, 2011, Volume: 54, Issue:2 Topics: Animals; Antifungal Agents; Candida glabrata; Candidiasis; Disease Models, Animal; Female; Humans; Mice; Mice, Inbred BALB C; Random Allocation; Triazoles; Vaginitis	2011
Efficacy of posaconazole in a murine disseminated infection by Candida tropicalis. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1 Topics: Animals; Antifungal Agents; Body Burden; Candida tropicalis; Candidiasis; Dose-Response Relationship, Drug; Immunosuppression Therapy; Kaplan-Meier Estimate; Male; Mice; Microbial Sensitivity Tests; Survival; Triazoles	2010
Examination of potential virulence factors of Candida tropicalis clinical isolates from hospitalized patients. Mycopathologia, 2010, Volume: 169, Issue:3 Topics: Amphotericin B; Antifungal Agents; Biofilms; Blood; Candida tropicalis; Candidiasis; Catheterization; Cell Adhesion; Cells, Cultured; Enzymes; Epithelial Cells; Equipment and Supplies; Fluconazole; Fungal Proteins; Hemolysin Proteins; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Urine; Virulence Factors; Voriconazole	2010
Successful use of topical voriconazole 1% alone as first-line antifungal therapy against Candida albicans keratitis. The Annals of pharmacotherapy, 2009, Volume: 43, Issue:12 Topics: Administration, Topical; Antifungal Agents; Candidiasis; Humans; Keratitis; Male; Middle Aged; Ophthalmic Solutions; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole	2009
Antifungal susceptibility of 205 Candida spp. isolated primarily during invasive Candidiasis and comparison of the Vitek 2 system with the CLSI broth microdilution and Etest methods. Journal of clinical microbiology, 2010, Volume: 48, Issue:1 Topics: Amphotericin B; Antifungal Agents; Automation; Candida; Candidiasis; Fluconazole; Humans; Intensive Care Units; Microbial Sensitivity Tests; Pyrimidines; Statistics as Topic; Triazoles; Voriconazole	2010
In vitro activity of antifungal combinations against Candida albicans biofilms. The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:2 Topics: Amphotericin B; Antifungal Agents; Austria; Biofilms; Candida albicans; Candidiasis; Caspofungin; Drug Synergism; Echinocandins; Fungemia; Humans; Intensive Care Units; Lipopeptides; Microbial Sensitivity Tests; Triazoles	2010
Candida spp. bloodstream infection: influence of antifungal treatment on outcome. The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:3 Topics: Adult; Aged; Antifungal Agents; Candidiasis; Drug Therapy, Combination; Echinocandins; Female; Fungemia; Humans; Male; Middle Aged; Survival Analysis; Treatment Outcome; Triazoles	2010
Antifungal susceptibility testing of Candida isolates from the Candida surveillance study. Journal of clinical microbiology, 2010, Volume: 48, Issue:4 Topics: Antifungal Agents; Candida; Candidiasis; Cross Infection; Echinocandins; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2010
Voriconazole-micafungin combination therapy for acute lymphoblastic leukemia. Pediatrics international : official journal of the Japan Pediatric Society, 2010, Volume: 52, Issue:1 Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Candida tropicalis; Candidiasis; Drug Therapy, Combination; Echinocandins; Follow-Up Studies; Fungemia; Humans; Infant; Lipopeptides; Male; Micafungin; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Aspergillosis; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole	2010
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion. Journal of clinical microbiology, 2010, Volume: 48, Issue:4 Topics: Antifungal Agents; Candida; Candidiasis; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2010
Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance Program. Diagnostic microbiology and infectious disease, 2010, Volume: 67, Issue:2 Topics: Africa; Americas; Antifungal Agents; Asia; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Europe; Fluconazole; Geography; Humans; Microbial Sensitivity Tests; Middle East; Pyrimidines; Triazoles; Voriconazole	2010
Renal allograft loss due to overwhelming invasive Candida infection. Kidney international, 2010, Volume: 77, Issue:8 Topics: Adult; Antifungal Agents; Candidiasis; Drug Therapy, Combination; Female; Fluconazole; Humans; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole	2010
Design, synthesis and antifungal activity of the novel water-soluble prodrug of antifungal triazole CS-758. Chemical & pharmaceutical bulletin, 2010, Volume: 58, Issue:6 Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candida albicans; Candidiasis; Humans; Mice; Microsomes, Liver; Mycoses; Prodrugs; Rats; Solubility; Triazoles	2010
Clinical characteristics and therapeutic analysis of invasive fungal infection in chronic severe hepatitis patients. Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2010, Volume: 35, Issue:6 Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Candidiasis; Hepatitis, Chronic; Humans; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole; Young Adult	2010
Successful topical application of caspofungin in the treatment of fungal keratitis refractory to voriconazole. Archives of ophthalmology (Chicago, Ill. : 1960), 2010, Volume: 128, Issue:7 Topics: Administration, Topical; Antifungal Agents; Candidiasis; Caspofungin; Corneal Ulcer; Drug Resistance, Fungal; Echinocandins; Eye Infections, Fungal; Female; Humans; Lipopeptides; Middle Aged; Pyrimidines; Triazoles; Voriconazole	2010
European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update. Bone marrow transplantation, 2011, Volume: 46, Issue:5 Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia; Lipopeptides; Micafungin; Mycoses; Neutropenia; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole	2011
Novel antifungal agents: triazolopyridines as inhibitors of beta-1,6-glucan synthesis. Bioorganic & medicinal chemistry, 2010, Aug-15, Volume: 18, Issue:16 Topics: Antifungal Agents; beta-Glucans; Candida; Candidiasis; Drug Stability; Humans; Imidazoles; Microsomes, Liver; Pyrazoles; Pyridines; Saccharomyces cerevisiae; Triazoles	2010
Antifungal activity of posaconazole against Candida spp. and non-Candida clinical yeasts isolates. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2010, Volume: 23, Issue:3 Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Mycoses; Triazoles; Yeasts	2010
Clinical features and outcomes of four patients with invasive fungal sinusitis. Auris, nasus, larynx, 2011, Volume: 38, Issue:2 Topics: Aged; Antifungal Agents; Aspergillosis; Biopsy; Blindness; Brain Infarction; Candidiasis; Cavernous Sinus; Combined Modality Therapy; Debridement; Early Diagnosis; Echinocandins; Fatal Outcome; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Lipopeptides; Magnetic Resonance Imaging; Male; Maxillary Sinusitis; Micafungin; Middle Aged; Orbit Evisceration; Orbital Diseases; Postoperative Complications; Pyrimidines; Sphenoid Sinusitis; Tomography, X-Ray Computed; Triazoles; Voriconazole	2011
Wild-type MIC distributions and epidemiological cutoff values for posaconazole and voriconazole and Candida spp. as determined by 24-hour CLSI broth microdilution. Journal of clinical microbiology, 2011, Volume: 49, Issue:2 Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2011
In vitro evaluation of antibiotic lock technique for the treatment of Candida albicans, C. glabrata, and C. tropicalis biofilms. Journal of Korean medical science, 2010, Volume: 25, Issue:12 Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Caspofungin; Catheter-Related Infections; Catheterization, Central Venous; Drug Administration Routes; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2010
In vitro susceptibility of a large collection of Candida Strains against fluconazole and voriconazole by using the CLSI disk diffusion assay. Mycopathologia, 2011, Volume: 171, Issue:6 Topics: Antifungal Agents; Brazil; Candida; Candidiasis; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Fluconazole; Humans; Pyrimidines; Triazoles; Voriconazole	2011
Comparison of the broth microdilution (BMD) method of the European Committee on Antimicrobial Susceptibility Testing with the 24-hour CLSI BMD method for testing susceptibility of Candida species to fluconazole, posaconazole, and voriconazole by use of ep Journal of clinical microbiology, 2011, Volume: 49, Issue:3 Topics: Antifungal Agents; Candida; Candidiasis; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2011
Posaconazole susceptibility of clinical yeast isolates determined by an agar diffusion and microdilution method. International journal of antimicrobial agents, 2011, Volume: 37, Issue:3 Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Triazoles	2011
A case of Candida haemulonii osteitis: clinical features, biochemical characteristics, and antifungal resistance profile. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2011, Volume: 17, Issue:7 Topics: Adult; Antifungal Agents; Candida; Candidiasis; Histocytochemistry; Humans; Male; Microbial Sensitivity Tests; Microscopy; Osteitis; Pyrimidines; Triazoles; United States; Vascular Surgical Procedures; Voriconazole	2011
Postoperative endophthalmitis caused by Candida parapsilosis: clinical features and treatment outcomes. Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye, 2011, Mar-10, Volume: 42 Online Topics: Aged; Antifungal Agents; Candidiasis; Cataract Extraction; Endophthalmitis; Eye Infections, Fungal; Female; Humans; Intravitreal Injections; Male; Middle Aged; Postoperative Complications; Pseudophakia; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Visual Acuity; Vitrectomy; Voriconazole	2011
Candida kefyr fungal enteritis following autologous BMT. Bone marrow transplantation, 2012, Volume: 47, Issue:3 Topics: Bone Marrow Transplantation; Candida; Candidiasis; Endoscopy; Enteritis; Hematologic Neoplasms; Humans; Male; Middle Aged; Tomography, X-Ray Computed; Triazoles; Waldenstrom Macroglobulinemia	2012
Broth microdilution and time-kill testing of Caspofungin, voriconazole, amphotericin B and their combinations against clinical isolates of Candida krusei. Mycopathologia, 2012, Volume: 173, Issue:1 Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Microbial Viability; Pyrimidines; Time Factors; Triazoles; Voriconazole	2012
Triazole and echinocandin MIC distributions with epidemiological cutoff values for differentiation of wild-type strains from non-wild-type strains of six uncommon species of Candida. Journal of clinical microbiology, 2011, Volume: 49, Issue:11 Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Echinocandins; Humans; Microbial Sensitivity Tests; Triazoles	2011
Invasive infection in an acute myeloblastic leukemia patient due to triazole-resistant Candida tropicalis. Diagnostic microbiology and infectious disease, 2011, Volume: 71, Issue:3 Topics: Aged; Antifungal Agents; Candida tropicalis; Candidiasis; Drug Resistance, Fungal; Fatal Outcome; Humans; Leukemia, Myeloid, Acute; Male; Microbial Sensitivity Tests; Shock, Septic; Triazoles	2011
Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy. PloS one, 2011, Volume: 6, Issue:9 Topics: Aged; Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Communicable Disease Control; Cross Infection; Echinocandins; Female; Fluconazole; Hospitals; Humans; Italy; Itraconazole; Lipopeptides; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole	2011
Breakthrough fungemia due to Candida glabrata during posaconazole prophylaxis in hematology patients treated with anidulafungin - report of 5 cases. Journal of chemotherapy (Florence, Italy), 2011, Volume: 23, Issue:5 Topics: Adult; Anidulafungin; Antifungal Agents; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Echinocandins; Female; Fungemia; Humans; Immunocompromised Host; Leukemia; Male; Middle Aged; Slovakia; Treatment Outcome; Triazoles	2011
Peptides of the constant region of antibodies display fungicidal activity. PloS one, 2012, Volume: 7, Issue:3 Topics: Animals; Antibodies; Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Cryptococcus neoformans; Disease Models, Animal; Drug Resistance, Fungal; Echinocandins; Erythrocytes; Female; Hemolysis; Humans; Immunoglobulin A; Immunoglobulin Constant Regions; Immunoglobulin G; Immunoglobulin M; Lipopeptides; Malassezia; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Peptides; Triazoles	2012
[Study on in vitro susceptibility of Candida spp. isolated from blood culture]. Le infezioni in medicina, 2012, Volume: 20, Issue:1 Topics: Amphotericin B; Antifungal Agents; Blood; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Hospitals; Humans; In Vitro Techniques; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Risk Factors; Triazoles; Voriconazole	2012
Amino acid substitutions in the Candida albicans sterol Δ5,6-desaturase (Erg3p) confer azole resistance: characterization of two novel mutants with impaired virulence. The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:9 Topics: Adult; Amino Acid Substitution; Animals; Antifungal Agents; Candida albicans; Candidiasis; Cell Membrane; Chemoprevention; Drug Resistance, Fungal; Female; Fluconazole; Gas Chromatography-Mass Spectrometry; Gene Expression Profiling; Humans; Mice; Microbial Sensitivity Tests; Middle Aged; Mutant Proteins; Oxidoreductases; Pyrimidines; Sterols; Triazoles; Virulence; Voriconazole	2012
Voriconazole inhibits biofilm formation in different species of the genus Candida. The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:10 Topics: Antifungal Agents; Biofilms; Candida; Candidiasis; Humans; Pyrimidines; Staining and Labeling; Tetrazolium Salts; Triazoles; Voriconazole	2012
Postantifungal effect of the combination of caspofungin with voriconazole and amphotericin B against clinical Candida krusei isolates. Medical mycology, 2013, Volume: 51, Issue:1 Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Caspofungin; Colony Count, Microbial; Drug Synergism; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole	2013
A targeted peritransplant antifungal strategy for the prevention of invasive fungal disease after lung transplantation: a sequential cohort analysis. Transplantation, 2012, Aug-15, Volume: 94, Issue:3 Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Cohort Studies; Echinocandins; Female; Humans; Lipopeptides; Lung Transplantation; Male; Micafungin; Middle Aged; Mycoses; Risk; Time Factors; Triazoles	2012
[Fungal infection secondary to treatment of Escherichia coli in a critically ill patient]. Ugeskrift for laeger, 2012, Aug-27, Volume: 174, Issue:35 Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Aspergillus; Candida; Candidiasis; Caspofungin; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Echinocandins; Escherichia coli; Fungemia; Humans; Lipopeptides; Male; Pyrimidines; Sepsis; Triazoles; Voriconazole	2012
Two clinical isolates of Candida glabrata exhibiting reduced sensitivity to amphotericin B both harbor mutations in ERG2. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:12 Topics: Amino Acid Sequence; Amphotericin B; Antifungal Agents; Azoles; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Pyrimidines; Saccharomyces cerevisiae; Steroid Isomerases; Sterols; Triazoles; Voriconazole	2012
Voriconazole stability in cement spacers. Medecine et maladies infectieuses, 2012, Volume: 42, Issue:11 Topics: Antifungal Agents; Arthroplasty, Replacement, Hip; Biofilms; Bone Cements; Candida glabrata; Candidiasis; Caspofungin; Device Removal; Dose-Response Relationship, Drug; Drug Implants; Drug Stability; Drug Therapy, Combination; Echinocandins; Hip Prosthesis; Humans; Infusions, Intravenous; Lipopeptides; Male; Middle Aged; Prostheses and Implants; Prosthesis-Related Infections; Pyrimidines; Triazoles; Voriconazole	2012
Voriconazole for Candida endophthalmitis. Ophthalmology, 2012, Volume: 119, Issue:11 Topics: Aged; Antifungal Agents; Candida albicans; Candidiasis; Endophthalmitis; Eye Infections, Fungal; Humans; Intravitreal Injections; Male; Pyrimidines; Tomography, Optical Coherence; Treatment Outcome; Triazoles; Urine; Voriconazole	2012
Antifungal susceptibility to amphotericin B, fluconazole, voriconazole, and flucytosine in Candida bloodstream isolates from 15 tertiary hospitals in Korea. Annals of laboratory medicine, 2012, Volume: 32, Issue:6 Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Pyrimidines; Republic of Korea; Tertiary Care Centers; Triazoles; Voriconazole	2012
[Endophthalmitis in course of candidosis--a case report]. Klinika oczna, 2012, Volume: 114, Issue:3 Topics: Adult; Antifungal Agents; Candidiasis; Endophthalmitis; Eye Infections, Fungal; Humans; Male; Pyrimidines; Treatment Outcome; Triazoles; Vitrectomy; Voriconazole	2012
Non-albicans Candida species in blood stream infections in a tertiary care hospital at New Delhi, India. The Indian journal of medical research, 2012, Volume: 136, Issue:6 Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Fluconazole; Flucytosine; Humans; Incidence; India; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Retrospective Studies; Tertiary Care Centers; Triazoles; Voriconazole	2012
Synthesis of novel water soluble benzylazolium prodrugs of lipophilic azole antifungals. Bioorganic & medicinal chemistry letters, 2002, Oct-07, Volume: 12, Issue:19 Topics: Animals; Antifungal Agents; Aspergillus fumigatus; Azoles; Candida albicans; Candidiasis; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Prodrugs; Rats; Solubility; Thiazoles; Triazoles	2002
Antifungal activity of amphotericin B, fluconazole, and voriconazole in an in vitro model of Candida catheter-related bloodstream infection. Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:11 Topics: Amphotericin B; Antifungal Agents; Area Under Curve; Candidiasis; Catheterization; Fluconazole; Half-Life; Microbial Sensitivity Tests; Microscopy, Electron; Pyrimidines; Triazoles; Voriconazole	2002
Successful treatment of Candida glabrata myocarditis with voriconazole. Scandinavian journal of infectious diseases, 2002, Volume: 34, Issue:10 Topics: Adult; Antifungal Agents; Candida glabrata; Candidiasis; Dose-Response Relationship, Drug; Drug Administration Schedule; Echocardiography, Transesophageal; Follow-Up Studies; Fungemia; Humans; Male; Myocarditis; Pyrimidines; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole	2002
Design, synthesis and antifungal activity of a novel water soluble prodrug of antifungal triazole. Bioorganic & medicinal chemistry letters, 2003, Jan-20, Volume: 13, Issue:2 Topics: Animals; Antifungal Agents; Aspergillosis; Biotransformation; Candidiasis; Chemical Phenomena; Chemistry, Physical; Drug Design; Half-Life; Haplorhini; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Models, Molecular; Molecular Conformation; Prodrugs; Rats; Solubility; Solvents; Triazoles; Water	2003
Efficacy of CS-758, a novel triazole, against experimental fluconazole-resistant oropharyngeal candidiasis in mice. Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:2 Topics: Animals; Antifungal Agents; Candidiasis; Drug Resistance, Fungal; Fluconazole; Male; Mice; Microbial Sensitivity Tests; Oropharynx; Tongue; Triazoles	2003
In vivo pharmacodynamics of a new triazole, ravuconazole, in a murine candidiasis model. Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:4 Topics: Animals; Antifungal Agents; Area Under Curve; Candidiasis; Disease Models, Animal; Female; Humans; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Thiazoles; Triazoles	2003
Susceptibility of clinical isolates of Candida glabrata to new triazoles. International journal of antimicrobial agents, 2003, Volume: 21, Issue:4 Topics: Antifungal Agents; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Triazoles	2003
Activities of fluconazole and voriconazole against 1,586 recent clinical isolates of Candida species determined by Broth microdilution, disk diffusion, and Etest methods: report from the ARTEMIS Global Antifungal Susceptibility Program, 2001. Journal of clinical microbiology, 2003, Volume: 41, Issue:4 Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Population Surveillance; Pyrimidines; Triazoles; Voriconazole	2003
Lack of cross-hepatotoxicity between fluconazole and voriconazole. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003, Apr-15, Volume: 36, Issue:8 Topics: Antifungal Agents; Candidiasis; Fluconazole; Humans; Liver; Liver Function Tests; Male; Pyrimidines; Transaminases; Triazoles; Voriconazole	2003
Prospective epidemiologic analysis of triazole-resistant nosocomial Candida glabrata isolated from patients at a comprehensive cancer center. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2002, Volume: 6, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida glabrata; Candidiasis; Cross Infection; Drug Resistance, Fungal; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Prospective Studies; Random Amplified Polymorphic DNA Technique; Triazoles	2002
Evaluation of the Etest and disk diffusion methods for determining susceptibilities of 235 bloodstream isolates of Candida glabrata to fluconazole and voriconazole. Journal of clinical microbiology, 2003, Volume: 41, Issue:5 Topics: Agar; Antifungal Agents; Candida glabrata; Candidiasis; Culture Media; Fluconazole; Fungemia; Humans; Microbial Sensitivity Tests; Pyrimidines; Quality Control; Triazoles; Voriconazole	2003
Trends in frequency and in vitro susceptibilities to antifungal agents, including voriconazole and anidulafungin, of Candida bloodstream isolates. Results from a six-year study (1996-2001). Diagnostic microbiology and infectious disease, 2003, Volume: 46, Issue:4 Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Echinocandins; Female; Fungemia; Hospitals, University; Humans; Male; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Retrospective Studies; Sensitivity and Specificity; Spain; Triazoles; Voriconazole	2003
[Update on voriconazole]. Deutsche medizinische Wochenschrift (1946), 2003, Aug-15, Volume: 128, Issue:33 Topics: Adult; Age Factors; AIDS-Related Opportunistic Infections; Antifungal Agents; Aspergillosis; Candidiasis; Child; Humans; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole	2003
[In vitro activity of fluconazole, voriconazole and posaconazole against Candida spp]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2003, Volume: 16, Issue:2 Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Species Specificity; Triazoles; Voriconazole	2003
[Mycostatin: a new fungistatic antibiotic for the treatment of moniliasis]. Prensa medica argentina, 1955, Jul-15, Volume: 42, Issue:28 Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Candidiasis; Dermatologic Agents; Nystatin; Triazoles	1955
[QUANTITATIVE STUDIES ON THE FUNGISTATIC ACTIVITY OF HUMAN SERUM TOWARDS CANDIDA ALBICANS]. Dermatologica, 1964, Volume: 128 Topics: Blood; Candida; Candida albicans; Candidiasis; Culture Media; Humans; Phenols; Research; Triazoles	1964
In vivo pharmacokinetics and pharmacodynamics of a new triazole, voriconazole, in a murine candidiasis model. Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:10 Topics: Administration, Oral; Animals; Antifungal Agents; Area Under Curve; Candida albicans; Candidiasis; Colony Count, Microbial; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Female; Fluconazole; Kidney; Mice; Microbial Sensitivity Tests; Neutropenia; Pyrimidines; Triazoles; Voriconazole	2003
Serum voriconazole levels following administration via percutaneous jejunostomy tube. Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:10 Topics: Aged; Candida glabrata; Candidiasis; Drug Administration Routes; Humans; Jejunostomy; Male; Pyrimidines; Triazoles; Voriconazole	2003
Phosphonooxymethyl prodrugs of the broad spectrum antifungal azole, ravuconazole: synthesis and biological properties. Bioorganic & medicinal chemistry letters, 2003, Nov-03, Volume: 13, Issue:21 Topics: Animals; Antifungal Agents; Candidiasis; Drug Stability; Female; Humans; Indicators and Reagents; Infusions, Intravenous; Mice; Mice, Inbred ICR; Prodrugs; Rats; Solubility; Structure-Activity Relationship; Survival; Thiazoles; Triazoles	2003
Voriconazole--superior in antimycotic treatment. Infection, 2003, Volume: 31, Issue:4 Topics: Antifungal Agents; Candida; Candidiasis; Clinical Trials as Topic; Female; Humans; Male; Pyrimidines; Sensitivity and Specificity; Treatment Outcome; Triazoles; Voriconazole	2003
Voriconazole salvage treatment of invasive candidiasis. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2003, Volume: 22, Issue:11 Topics: Adolescent; Adult; Aged; Antifungal Agents; Candida; Candidiasis; Child; Child, Preschool; Cohort Studies; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Fungemia; Humans; Male; Middle Aged; Prospective Studies; Pyrimidines; Risk Assessment; Salvage Therapy; Severity of Illness Index; Treatment Outcome; Triazoles; Voriconazole	2003
Comparison of the susceptibilities of Candida spp. to fluconazole and voriconazole in a 4-year global evaluation using disk diffusion. Journal of clinical microbiology, 2003, Volume: 41, Issue:12 Topics: Antifungal Agents; Candida; Candidiasis; Diffusion; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2003
National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin. The Journal of antimicrobial chemotherapy, 2004, Volume: 53, Issue:2 Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Echinocandins; Flucytosine; Humans; Itraconazole; Japan; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2004
Pharmacodynamics of a new triazole, posaconazole, in a murine model of disseminated candidiasis. Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:1 Topics: Animals; Antifungal Agents; Area Under Curve; Candida albicans; Candidiasis; Colony Count, Microbial; Dose-Response Relationship, Drug; Female; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Triazoles	2004
Multicenter comparison of the Sensititre YeastOne colorimetric antifungal panel with the NCCLS M27-A2 reference method for testing new antifungal agents against clinical isolates of Candida spp. Journal of clinical microbiology, 2004, Volume: 42, Issue:2 Topics: Antifungal Agents; Candida; Candidiasis; Caspofungin; Colorimetry; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Reproducibility of Results; Sensitivity and Specificity; Triazoles	2004
Comparison of two microdilution methods for testing susceptibility of Candida spp. to voriconazole. Journal of clinical microbiology, 2004, Volume: 42, Issue:2 Topics: Antifungal Agents; Candida; Candidiasis; Colorimetry; Microbial Sensitivity Tests; Mycology; Pyrimidines; Sensitivity and Specificity; Triazoles; Voriconazole	2004
[symbol: see text]Caspofungin and [symbol: see text]voriconazole for fungal infections. Drug and therapeutics bulletin, 2004, Volume: 42, Issue:1 Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Echinocandins; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole	2004
In vitro susceptibilities of rare Candida bloodstream isolates to ravuconazole and three comparative antifungal agents. Diagnostic microbiology and infectious disease, 2004, Volume: 48, Issue:2 Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucytosine; Fungemia; Humans; Microbial Sensitivity Tests; Thiazoles; Triazoles	2004
Secondary antifungal prophylaxis with voriconazole to adhere to scheduled treatment in leukemic patients and stem cell transplant recipients. Bone marrow transplantation, 2004, Volume: 33, Issue:9 Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Female; Graft vs Host Disease; Humans; Leukemia; Male; Middle Aged; Prognosis; Prospective Studies; Pyrimidines; Recurrence; Risk; Stem Cell Transplantation; Transplantation, Homologous; Triazoles; Voriconazole	2004
Voriconazole: new preparation. Invasive aspergillosis: benefits to be confirmed. Prescrire international, 2004, Volume: 13, Issue:69 Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Drug Interactions; Fusarium; Humans; Immunocompromised Host; Mycetoma; Mycoses; Pyrimidines; Scedosporium; Treatment Outcome; Triazoles	2004
Use of voriconazole in candida retinitis. Eye (London, England), 2005, Volume: 19, Issue:4 Topics: Adult; Antifungal Agents; Candidiasis; Eye Infections, Fungal; Fatal Outcome; Female; Humans; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole	2005
Caspofungin: new indication. No progress in invasive candidiasis. Prescrire international, 2004, Volume: 13, Issue:70 Topics: Amphotericin B; Antifungal Agents; Candidiasis; Fluconazole; France; Humans; Peptides; Pyrimidines; Triazoles	2004
In vitro activities of voriconazole (UK-109, 496), fluconazole, itraconazole and amphotericin B against 132 non-albicans bloodstream yeast isolates (CANARI study). Mycoses, 2004, Volume: 47, Issue:5-6 Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Saccharomyces cerevisiae; Triazoles; Voriconazole	2004
Fungal peritonitis at a tertiary care community teaching hospital: epidemiology, treatments, and outcome over a 3 year timespan. Mycoses, 2004, Volume: 47, Issue:5-6 Topics: Antifungal Agents; Candidiasis; Hospitals, Teaching; Humans; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Prognosis; Treatment Outcome; Triazoles	2004
Alternatives to amphotericin B for Candida rugosa infection. The Journal of antimicrobial chemotherapy, 2004, Volume: 54, Issue:2 Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Colony Count, Microbial; Fluconazole; Kidney; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Organ Size; Pyrimidines; Spleen; Survival Analysis; Triazoles; Voriconazole	2004
Pfizer's Vfend as effective in treating candidemia as two-drug standard of care according to study. Infection, 2004, Volume: 32, Issue:3 Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fungemia; Humans; Pyrimidines; Randomized Controlled Trials as Topic; Treatment Outcome; Triazoles; Voriconazole	2004
In vitro activity of voriconazole and other antifungal agents against clinical isolates of Candida glabrata and Candida krusei. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2004, Volume: 23, Issue:8 Topics: Antifungal Agents; Candida; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Humans; In Vitro Techniques; Italy; Microbial Sensitivity Tests; Pyrimidines; Sampling Studies; Sensitivity and Specificity; Triazoles; Voriconazole	2004
In vitro activities of ravuconazole and four other antifungal agents against fluconazole-resistant or -susceptible clinical yeast isolates. Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:8 Topics: Antifungal Agents; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Thiazoles; Triazoles; Yeasts	2004
Influence of voriconazole and fluconazole on reconstituted multilayered oesophageal epithelium infected by Candida albicans. Mycoses, 2004, Volume: 47, Issue:7 Topics: Antifungal Agents; Candida albicans; Candidiasis; Cell Line, Tumor; Epithelial Cells; Esophagitis; Esophagus; Fluconazole; Humans; Microbial Sensitivity Tests; Models, Biological; Pyrimidines; Triazoles; Voriconazole	2004
In vitro activity of voriconazole against Candida species isolated in Taiwan. International journal of antimicrobial agents, 2004, Volume: 24, Issue:3 Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Taiwan; Triazoles; Voriconazole	2004
Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Sep-01, Volume: 39, Issue:5 Topics: Adult; Aspergillosis; Aspergillus; Candida glabrata; Candidiasis; Child; Drug Resistance, Fungal; Female; Fungemia; Fungi; Humans; Immunocompromised Host; Male; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Retrospective Studies; Stem Cell Transplantation; Triazoles; Voriconazole; Zygomycosis	2004
Clinical evaluation of the Sensititre YeastOne colorimetric antifungal plate for antifungal susceptibility testing of the new triazoles voriconazole, posaconazole, and ravuconazole. Journal of clinical microbiology, 2004, Volume: 42, Issue:10 Topics: Antifungal Agents; Candida; Candidiasis; Humans; Microbial Sensitivity Tests; Pyrimidines; Reagent Kits, Diagnostic; Thiazoles; Triazoles; Voriconazole	2004
Altered susceptibility of Candida glabrata bloodstream isolates to triazoles at clinically relevant pH values: comparison of the NCCLS M27-A2, Sensititre YeastOne, and Etest methods. Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:11 Topics: Antifungal Agents; Candida glabrata; Candidiasis; Culture Media; Fluconazole; Hydrogen-Ion Concentration; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2004
In vitro pharmacodynamic characteristics of amphotericin B, caspofungin, fluconazole, and voriconazole against bloodstream isolates of infrequent Candida species from patients with hematologic malignancies. Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:11 Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Caspofungin; Colony Count, Microbial; Echinocandins; Fluconazole; Hematologic Neoplasms; Humans; Kinetics; Lipopeptides; Microbial Sensitivity Tests; Models, Biological; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2004
Posaconazole therapy for severe abdominal candidiasis: a case report. Revista iberoamericana de micologia, 2004, Volume: 21, Issue:2 Topics: Abdomen; Aged; Antifungal Agents; Candidiasis; Cysts; Female; Humans; Liver Diseases; Postoperative Complications; Severity of Illness Index; Triazoles	2004
[Efficiency of voriconazole in fungal keratitis caused by candida albicans]. Archivos de la Sociedad Espanola de Oftalmologia, 2004, Volume: 79, Issue:11 Topics: Aged; Antifungal Agents; Candidiasis; Female; Humans; Keratitis; Pyrimidines; Triazoles; Voriconazole	2004
Combined use of sirolimus and voriconazole in renal transplantation: a report of two cases. Transplantation proceedings, 2004, Volume: 36, Issue:9 Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candidiasis; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Lung Diseases, Fungal; Male; Middle Aged; Postoperative Complications; Pyrimidines; Sirolimus; Triazoles; Voriconazole	2004
Candida infection of the subacromial bursa. A case report. The Journal of bone and joint surgery. American volume, 2005, Volume: 87, Issue:1 Topics: Acromion; Aged; Anti-Inflammatory Agents; Antifungal Agents; Bupivacaine; Bursa, Synovial; Bursitis; Candidiasis; Decompression, Surgical; Humans; Injections, Intra-Articular; Lidocaine; Male; Methylprednisolone; Methylprednisolone Acetate; Pyrimidines; Shoulder Impingement Syndrome; Triazoles; Voriconazole	2005
Management of endogenous fungal endophthalmitis with voriconazole and caspofungin. American journal of ophthalmology, 2005, Volume: 139, Issue:1 Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Aqueous Humor; Biological Availability; Candidiasis; Caspofungin; Chromatography, High Pressure Liquid; Echinocandins; Endophthalmitis; Eye Infections, Fungal; Female; Fungemia; Humans; Infusions, Intravenous; Injections; Lipopeptides; Male; Middle Aged; Peptides, Cyclic; Pyrimidines; Retrospective Studies; Triazoles; Vitreous Body; Voriconazole	2005
Interaction between posaconazole and amphotericin B in concomitant treatment against Candida albicans in vivo. Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:2 Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Drug Interactions; Male; Mice; Survival Analysis; Triazoles	2005
[Drugs used in prophylaxis and treatment of fungal infections in immunosuppressed children]. Przeglad lekarski, 2004, Volume: 61 Suppl 2 Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Child; Drug Resistance, Fungal; Echinocandins; Humans; Immunocompromised Host; Lipopeptides; Mycoses; Neoplasms; Peptides, Cyclic; Pyrimidines; Risk Factors; Triazoles; Voriconazole	2004
Infection of a total knee prosthesis by Candida glabrata: a case report. Acta orthopaedica Belgica, 2005, Volume: 71, Issue:1 Topics: Aged; Antifungal Agents; Arthroplasty, Replacement, Knee; Candida glabrata; Candidiasis; Female; Humans; Pyrimidines; Surgical Wound Infection; Treatment Outcome; Triazoles; Voriconazole	2005
Intravenous voriconazole therapy in a preterm infant. Pharmacotherapy, 2005, Volume: 25, Issue:6 Topics: Amphotericin B; Antifungal Agents; Candidiasis; Humans; Infant, Newborn; Infant, Premature; Infusions, Intravenous; Pyrimidines; Triazoles; Voriconazole	2005
Treatment of candida chorioretinitis with voriconazole. Korean journal of ophthalmology : KJO, 2005, Volume: 19, Issue:1 Topics: Antifungal Agents; Candidiasis; Chorioretinitis; Eye Infections, Fungal; Female; Fungemia; Humans; Middle Aged; Pyrimidines; Triazoles; Voriconazole	2005
In vitro and in vivo antifungal activities of FX0685, a novel triazole antifungal agent with potent activity against fluconazole-resistant Candida albicans. Medical mycology, 2005, Volume: 43, Issue:3 Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Resistance, Fungal; Fluconazole; Injections, Intravenous; Male; Mice; Mice, Inbred CBA; Mice, Inbred DBA; Microbial Sensitivity Tests; Species Specificity; Triazoles	2005
[Treatment of invasive fungal infections with voriconazole. Evaluation of experience with compassionate use of voriconazole in Spain]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2005, Volume: 18, Issue:2 Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Child; Child, Preschool; Drug Resistance, Fungal; Female; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Spain; Treatment Outcome; Triazoles; Voriconazole	2005
Comparison of visual 24-hour and spectrophotometric 48-hour MICs to CLSI reference microdilution MICs of fluconazole, itraconazole, posaconazole, and voriconazole for Candida spp.: a collaborative study. Journal of clinical microbiology, 2005, Volume: 43, Issue:9 Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reference Standards; Reproducibility of Results; Spectrophotometry; Triazoles; Voriconazole	2005
Species distribution and antifungal susceptibility of Candida bloodstream isolates in a tertiary medical center in Israel. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2005, Volume: 24, Issue:9 Topics: Academic Medical Centers; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungemia; Humans; Israel; Itraconazole; Pyrimidines; Species Specificity; Triazoles; Voriconazole	2005
Emergence of Candida albicans fungemia during voriconazole therapy. The Journal of infection, 2005, Volume: 51, Issue:3 Topics: Adult; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Fungal; Fatal Outcome; Female; Fungemia; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2005
Hydroxylated analogues of the orally active broad spectrum antifungal, Sch 51048 (1), and the discovery of posaconazole [Sch 56592; 2 or (S,S)-5]. Bioorganic & medicinal chemistry letters, 2006, Jan-01, Volume: 16, Issue:1 Topics: Alcohols; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Drug Design; Drug Evaluation, Preclinical; Haplorhini; Humans; Immunosuppressive Agents; Mice; Models, Chemical; Time Factors; Triazoles	2006
Septic Candida krusei thrombophlebitis of inferior vena cava with persistent fungemia successfully treated by new antifungal agents. Medical mycology, 2005, Volume: 43, Issue:8 Topics: Adult; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Female; Fungemia; Humans; Intensive Care Units; Lipopeptides; Peptides, Cyclic; Pyrimidines; Thrombophlebitis; Triazoles; Vena Cava, Inferior; Voriconazole	2005
Voriconazole. Indian pediatrics, 2005, Volume: 42, Issue:12 Topics: Antifungal Agents; Aspergillosis; Candidiasis; Drug Interactions; Humans; Pyrimidines; Triazoles; Voriconazole	2005
Triazole cross-resistance among Candida spp.: case report, occurrence among bloodstream isolates, and implications for antifungal therapy. Journal of clinical microbiology, 2006, Volume: 44, Issue:2 Topics: Antifungal Agents; Blood; Candida; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Fatal Outcome; Female; Fluconazole; Fungemia; Humans; Microbial Sensitivity Tests; Middle Aged; Triazoles	2006
Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2006, Volume: 12, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Candidiasis; Child; Child, Preschool; Cross Infection; Drug Resistance, Fungal; Female; Fungemia; Hospitals, University; Humans; Infant; Infant, Newborn; Italy; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Triazoles	2006
Breakthrough fungemia caused by fluconazole-resistant Candida albicans with decreased susceptibility to voriconazole in patients with hematologic malignancies. Haematologica, 2006, Volume: 91, Issue:2 Topics: Candida albicans; Candidiasis; Drug Resistance; Fluconazole; Fungemia; Hematologic Neoplasms; Humans; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole	2006
[Voriconazole at Saint Louis Hospital (Paris): Analysis of two-years of compassionate use]. Presse medicale (Paris, France : 1983), 2006, Volume: 35, Issue:2 Pt 1 Topics: Acute Disease; Antifungal Agents; Aspergillosis; Candidiasis; Cohort Studies; Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia; Mycoses; Pyrimidines; Retrospective Studies; Time Factors; Treatment Outcome; Triazoles; Voriconazole	2006
Candidaemia secondary to intravascular catheter colonisation? Lancet (London, England), 2006, Mar-04, Volume: 367, Issue:9512 Topics: Amphotericin B; Antifungal Agents; Candidiasis; Catheterization, Central Venous; Equipment Contamination; Humans; Pyrimidines; Triazoles; Voriconazole	2006
Oropharyngeal candidiasis: a new treatment option. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Apr-15, Volume: 42, Issue:8 Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis; Candidiasis, Oral; Clinical Trials as Topic; Humans; Pharyngeal Diseases; Triazoles	2006
Successful treatment of Candida parapsilosis mural endocarditis with combined caspofungin and voriconazole. BMC infectious diseases, 2006, Apr-11, Volume: 6 Topics: Antifungal Agents; Candidiasis; Caspofungin; Drug Therapy, Combination; Echinocandins; Endocarditis; Female; Humans; Lipopeptides; Middle Aged; Peptides, Cyclic; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole	2006
Clinical significance of azole antifungal drug cross-resistance in Candida glabrata. Journal of clinical microbiology, 2006, Volume: 44, Issue:5 Topics: Adult; Antifungal Agents; Candida glabrata; Candidiasis; Child; Drug Resistance, Fungal; Fluconazole; Fungemia; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Middle Aged; Pyrimidines; Triazoles; Voriconazole	2006
Spondylodiscitis caused by Candida krusei: case report and susceptibility patterns. Journal of clinical microbiology, 2006, Volume: 44, Issue:5 Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Caspofungin; Discitis; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Magnetic Resonance Imaging; Male; Microbial Sensitivity Tests; Middle Aged; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2006
In vitro activities of new and conventional antimycotics against fluconazole-susceptible and non-susceptible Brazilian Candida spp. isolates. Mycoses, 2006, Volume: 49, Issue:3 Topics: Antifungal Agents; Brazil; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Quinazolines; Thiazoles; Triazoles	2006
Control of a Candida glabrata prosthetic endovascular infection with posaconazole. Medical mycology, 2006, Volume: 44, Issue:3 Topics: Candida glabrata; Candidiasis; Drug Resistance, Fungal; Drug Therapy, Combination; Fluconazole; Humans; Male; Middle Aged; Portasystemic Shunt, Transjugular Intrahepatic; Triazoles	2006
In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:6 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Cryptococcosis; Cryptococcus; Drug Resistance, Fungal; Fluconazole; Fungi; Humans; In Vitro Techniques; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole	2006
Correlation between microdilution, E-test, and disk diffusion methods for antifungal susceptibility testing of posaconazole against Candida spp. Journal of clinical microbiology, 2006, Volume: 44, Issue:6 Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis; Drug Resistance, Fungal; Fungemia; Humans; Microbial Sensitivity Tests; Triazoles	2006
Antifungal effect of voriconazole on intracellular Candida glabrata, Candida krusei and Candida parapsilosis in human monocyte-derived macrophages. Journal of medical microbiology, 2006, Volume: 55, Issue:Pt 7 Topics: Antifungal Agents; Candida; Candidiasis; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Humans; Macrophages; Pyrimidines; Triazoles; Voriconazole	2006
A case of pulmonary aspergillosis with lack of response to caspofungin. Revista iberoamericana de micologia, 2006, Volume: 23, Issue:2 Topics: Acute Disease; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bone Marrow Diseases; Candidiasis; Caspofungin; Combined Modality Therapy; Contraindications; Echinocandins; Fatal Outcome; Female; Hematopoietic Stem Cell Transplantation; Hepatitis; Humans; Immunocompromised Host; Immunosuppressive Agents; Leukemia, Myeloid; Lipopeptides; Lung Diseases, Fungal; Middle Aged; Peptides, Cyclic; Postoperative Complications; Pyrimidines; Splenic Diseases; Triazoles; Voriconazole	2006
Use of the BIOMIC Video System to evaluate the susceptibility of clinical yeast isolates to fluconazole and voriconazole by a disk diffusion method. Acta microbiologica et immunologica Hungarica, 2006, Volume: 53, Issue:2 Topics: Candida; Candidiasis; Fluconazole; Humans; Image Processing, Computer-Assisted; Microbial Sensitivity Tests; Microscopy, Video; Pyrimidines; Triazoles; Voriconazole	2006
Salvage therapy of refractory chronic disseminated candidiasis in a patient with acute myeloid leukaemia and secondary prophylaxis during allogeneic stem cell transplantation. Mycoses, 2006, Volume: 49 Suppl 1 Topics: Adult; Antifungal Agents; Candidiasis; Chemoprevention; Drug Resistance, Fungal; Esophagitis; Humans; Leukemia, Myeloid, Acute; Male; Mycoses; Salvage Therapy; Stem Cell Transplantation; Transplantation, Homologous; Triazoles	2006
[Candida albicans induced spondylodiscitis of the cervical spine of a polytraumatized patient]. Der Unfallchirurg, 2006, Volume: 109, Issue:11 Topics: Adult; Antifungal Agents; Candidiasis; Cervical Vertebrae; Combined Modality Therapy; Discitis; Epidural Abscess; Fluconazole; Follow-Up Studies; Head Movements; Humans; Lung Diseases, Fungal; Male; Multiple Trauma; Pyrimidines; Radiography; Triazoles; Voriconazole	2006
Severe Candida albicans panophthalmitis treated with all available and potentially effective antifungal drugs: fluconazole, liposomal amphotericin B, caspofungin, and voriconazole. Scandinavian journal of infectious diseases, 2006, Volume: 38, Issue:10 Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Humans; Lipopeptides; Male; Middle Aged; Panophthalmitis; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2006
In vitro and in vivo activities of HQQ-3, a new triazole antifungal agent. Biological & pharmaceutical bulletin, 2006, Volume: 29, Issue:10 Topics: Animals; Antifungal Agents; Candidiasis; Mice; Microbial Sensitivity Tests; Triazoles	2006
Candida guilliermondii, an opportunistic fungal pathogen with decreased susceptibility to fluconazole: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program. Journal of clinical microbiology, 2006, Volume: 44, Issue:10 Topics: Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Global Health; Humans; Lipopeptides; Peptides, Cyclic; Population Surveillance; Pyrimidines; Triazoles; Voriconazole	2006
Candida rugosa, an emerging fungal pathogen with resistance to azoles: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program. Journal of clinical microbiology, 2006, Volume: 44, Issue:10 Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Global Health; Humans; Population Surveillance; Pyrimidines; Triazoles; Voriconazole	2006
Echinocandins for candidemia. The New England journal of medicine, 2006, Dec-28, Volume: 355, Issue:26 Topics: Antifungal Agents; Candidiasis; Fluconazole; Fungemia; Humans; Pyrimidines; Triazoles; Voriconazole	2006
In vitro activities of voriconazole and five licensed antifungal agents against Candida dubliniensis: comparison of CLSI M27-A2, Sensititre YeastOne, disk diffusion, and Etest methods. Microbial drug resistance (Larchmont, N.Y.), 2006,Winter, Volume: 12, Issue:4 Topics: Antifungal Agents; Candida; Candidiasis; Colorimetry; Indicator Dilution Techniques; Microbial Sensitivity Tests; Mycological Typing Techniques; Pyrimidines; Reference Standards; Triazoles; Voriconazole; Yeasts	2006
Voriconazole-induced pseudoporphyria. Photodermatology, photoimmunology & photomedicine, 2007, Volume: 23, Issue:1 Topics: Antifungal Agents; Candidiasis; Drug Eruptions; Female; Humans; Middle Aged; Porphyria, Acute Intermittent; Pyrimidines; Triazoles; Voriconazole	2007
Caspofungin for the treatment of azole resistant candidemia in a premature infant. Journal of perinatology : official journal of the California Perinatal Association, 2007, Volume: 27, Issue:2 Topics: Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Drug Resistance, Microbial; Echinocandins; Humans; Hypercalcemia; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Lipopeptides; Male; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2007
Evaluation of Etest and disk diffusion methods compared with broth microdilution antifungal susceptibility testing of clinical isolates of Candida spp. against posaconazole. Journal of clinical microbiology, 2007, Volume: 45, Issue:6 Topics: Agar; Antifungal Agents; Candida; Candidiasis; Culture Media; Disk Diffusion Antimicrobial Tests; Humans; Microbial Sensitivity Tests; Triazoles	2007
Species distribution and antifungal susceptibility patterns of Candida spp. bloodstream isolates from a Brazilian tertiary care hospital. Mycopathologia, 2007, Volume: 163, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Brazil; Candida; Candidiasis; Drug Resistance, Fungal; Female; Fluconazole; Hospitals; Humans; Intensive Care Units; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Risk Factors; Triazoles; Voriconazole	2007
The effects of caspofungin and voriconazole in experimental Candida endophthalmitis. Current eye research, 2007, Volume: 32, Issue:1 Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Colony Count, Microbial; Cornea; Disease Models, Animal; Echinocandins; Endophthalmitis; Eye Infections, Fungal; Itraconazole; Lipopeptides; Peptides, Cyclic; Pyrimidines; Rabbits; Triazoles; Voriconazole	2007
Posaconazole. Nature reviews. Drug discovery, 2007, Volume: 6, Issue:3 Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Candidiasis; Capsules; Drug Approval; Drug Design; Economics, Pharmaceutical; Fluconazole; Humans; Injections, Intravenous; Itraconazole; Molecular Structure; Randomized Controlled Trials as Topic; Suspensions; Technology, Pharmaceutical; Treatment Failure; Triazoles; United States	2007
Acquired resistance to echinocandins in Candida albicans: case report and review. The Journal of antimicrobial chemotherapy, 2007, Volume: 59, Issue:6 Topics: Adult; Amino Acid Sequence; Amino Acid Substitution; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Genotype; HIV Infections; HIV-1; Humans; Lipopeptides; Lipoproteins; Male; Micafungin; Microbial Sensitivity Tests; Molecular Sequence Data; Peptides, Cyclic; Pyrimidines; Treatment Failure; Triazoles; Voriconazole	2007
Posaconazole susceptibility testing against Candida species: comparison of broth microdilution and E-test methods. Mycoses, 2007, Volume: 50, Issue:3 Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis; Dimethyl Sulfoxide; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Polyethylene Glycols; Solvents; Triazoles	2007
Measurement of voriconazole activity against Candida albicans, C. glabrata, and C. parapsilosis isolates using time-kill methods validated by high-performance liquid chromatography. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:8 Topics: Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candidiasis; Chromatography, High Pressure Liquid; Culture Media; Dose-Response Relationship, Drug; Fungemia; Humans; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole	2007
Does one voriconazole breakpoint suit all Candida species? Journal of clinical microbiology, 2007, Volume: 45, Issue:6 Topics: Antifungal Agents; Candida; Candidiasis; Humans; Microbial Sensitivity Tests; Pyrimidines; Species Specificity; Triazoles; Voriconazole	2007
Posaconazole for azole-refractory candidiasis in patients with HIV infection. AIDS alert, 2007, Volume: 22, Issue:5 Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Drug Administration Schedule; Esophageal Diseases; Humans; Mouth Diseases; Pharyngeal Diseases; Triazoles	2007
Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole. Bone marrow transplantation, 2007, Volume: 40, Issue:5 Topics: Antifungal Agents; Aspergillosis; Candidiasis; Data Collection; Drug Evaluation; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Mycoses; Premedication; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole; Zygomycosis	2007
Voriconazole: a broad spectrum triazole for the treatment of serious and invasive fungal infections. Future microbiology, 2006, Volume: 1, Issue:4 Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Candidiasis; Drug Evaluation; Drug Resistance, Fungal; Fluconazole; Humans; Injections, Intravenous; Molecular Structure; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole	2006
Successfully treated Candida krusei infection of the lumbar spine with combined caspofungin/posaconazole therapy. Medical mycology, 2008, Volume: 46, Issue:1 Topics: Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Middle Aged; Osteomyelitis; Triazoles	2008
In vitro activities of voriconazole as a triazole derivative and caspofungin as an echinocandin were compared with those of some antifungal agents against Candida species isolated from clinical specimens. Japanese journal of infectious diseases, 2007, Volume: 60, Issue:5 Topics: Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Sputum; Triazoles; Voriconazole	2007
Triple antifungal therapy for severe systemic candidiasis allowed performance of allogeneic stem cell transplantation. European journal of medical research, 2007, Aug-16, Volume: 12, Issue:8 Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Candidiasis; Caspofungin; Drug Therapy, Combination; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia-Lymphoma, Adult T-Cell; Lipopeptides; Liposomes; Male; Peptides, Cyclic; Pyrimidines; Transplantation Conditioning; Transplantation, Homologous; Triazoles; Voriconazole	2007
Species distribution and susceptibility to azole antifungals of Candida bloodstream isolates from eight university hospitals in Korea. Yonsei medical journal, 2007, Oct-31, Volume: 48, Issue:5 Topics: Antifungal Agents; Azoles; Bacteremia; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Hospitals, University; Humans; Itraconazole; Microbial Sensitivity Tests; Population Surveillance; Pyrimidines; Triazoles; Voriconazole	2007
Comparison of disc diffusion assay with the CLSI reference method (M27-A2) for testing in vitro posaconazole activity against common and uncommon yeasts. The Journal of antimicrobial chemotherapy, 2008, Volume: 61, Issue:1 Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Reference Standards; Reproducibility of Results; Triazoles	2008
Activities of fluconazole and voriconazole against bloodstream isolates of Candida glabrata and Candida krusei: a 14-year study in a Spanish tertiary medical centre. International journal of antimicrobial agents, 2008, Volume: 31, Issue:3 Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungemia; Hospitals; Humans; Microbial Sensitivity Tests; Pyrimidines; Spain; Triazoles; Voriconazole	2008
Posaconazole activity against Candida glabrata after exposure to caspofungin or amphotericin B. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:2 Topics: Amphotericin B; Animals; Antifungal Agents; Candida glabrata; Candidiasis; Caspofungin; Colony Count, Microbial; Drug Administration Schedule; Echinocandins; Humans; Kidney; Lipopeptides; Male; Mice; Microbial Sensitivity Tests; Treatment Outcome; Triazoles	2008
Managing Candida endophthalmitis (Recurrent Candida albicans endophthalmitis in an immunocompromised host. Vol. 42[1]). Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2007, Volume: 42, Issue:6 Topics: Amphotericin B; Antifungal Agents; Candidiasis; Endophthalmitis; Eye Infections, Fungal; Humans; Immunocompromised Host; Postoperative Complications; Pyrimidines; Recurrence; Triazoles; Voriconazole	2007
Selection of a surrogate agent (fluconazole or voriconazole) for initial susceptibility testing of posaconazole against Candida spp.: results from a global antifungal surveillance program. Journal of clinical microbiology, 2008, Volume: 46, Issue:2 Topics: Antifungal Agents; Biomarkers; Candida; Candidiasis; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Regression Analysis; Triazoles; Voriconazole	2008
Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008, Jan-15, Volume: 46, Issue:2 Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Candidiasis; Chromatography, High Pressure Liquid; Drug Monitoring; Female; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole	2008
High-dose voriconazole in a critically ill pediatric patient with neuroblastoma. The Pediatric infectious disease journal, 2008, Volume: 27, Issue:2 Topics: Antifungal Agents; Candidiasis; Child, Preschool; Critical Illness; Humans; Lung Diseases; Male; Neuroblastoma; Pyrimidines; Triazoles; Voriconazole	2008
Geographic and temporal trends in isolation and antifungal susceptibility of Candida parapsilosis: a global assessment from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005. Journal of clinical microbiology, 2008, Volume: 46, Issue:3 Topics: Africa; Antifungal Agents; Asia; Candida; Candidiasis; Drug Resistance, Fungal; Echinocandins; Europe; Fluconazole; Fungemia; Global Health; Humans; Latin America; Microbial Sensitivity Tests; Middle East; North America; Population Surveillance; Pyrimidines; Triazoles; Voriconazole	2008
Beta-D-glucan detection test: a step toward preemptive therapy for fungal infections in leukemic patients? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008, Mar-15, Volume: 46, Issue:6 Topics: Antifungal Agents; Antigens, Fungal; Aspergillosis; beta-Glucans; Candidiasis; Chemoprevention; Humans; Leukemia; Proteoglycans; Triazoles	2008
Bile aspiration for diagnosis of Candida glabrata cholecystitis. Infection, 2008, Volume: 36, Issue:2 Topics: Acalculous Cholecystitis; Aged; Animals; Antifungal Agents; Bile; Biopsy, Needle; Candida glabrata; Candidiasis; Female; Humans; Pyrimidines; Triazoles; Voriconazole	2008
Voriconazole in newborns. Indian pediatrics, 2008, Volume: 45, Issue:3 Topics: Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Critical Illness; Humans; Infant, Newborn; Pyrimidines; Triazoles; Voriconazole	2008
Posaconazole against Candida glabrata isolates with various susceptibilities to fluconazole. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:6 Topics: Animals; Antifungal Agents; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Kidney; Male; Mice; Microbial Sensitivity Tests; Treatment Outcome; Triazoles	2008
Activities and ultrastructural effects of antifungal combinations against simulated Candida endocardial vegetations. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:7 Topics: Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Drug Resistance, Fungal; Drug Therapy, Combination; Echinocandins; Endocarditis; Flucytosine; Humans; In Vitro Techniques; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Models, Biological; Pyrimidines; Triazoles; Voriconazole	2008
[Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates]. Mikrobiyoloji bulteni, 2008, Volume: 42, Issue:1 Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Drug Interactions; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole	2008
[Correlation of in vitro and in vivo actions of azole antimycotics]. Mykosen, 1984, Volume: 27, Issue:1 Topics: Animals; Antifungal Agents; Candidiasis; Flucytosine; In Vitro Techniques; Ketoconazole; Male; Mice; Mice, Inbred Strains; Triazoles	1984
Antimycotic activity of BAY N 7133 in animal experiments. The Journal of antimicrobial chemotherapy, 1984, Volume: 13, Issue:5 Topics: Administration, Oral; Administration, Topical; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Female; Flucytosine; Guinea Pigs; Hair; Infusions, Parenteral; Ketoconazole; Male; Mice; Mycoses; Triazoles	1984
Terconazole - a new broad-spectrum antifungal. Chemotherapy, 1983, Volume: 29, Issue:5 Topics: Administration, Oral; Animals; Antifungal Agents; Candidiasis; Candidiasis, Cutaneous; Candidiasis, Vulvovaginal; Dermatomycoses; Dose-Response Relationship, Drug; Female; Fungi; Guinea Pigs; Male; Mice; Rats; Rats, Inbred Strains; Triazoles; Trichomonas Vaginitis; Turkeys; Yeasts	1983
Azole-resistant oropharyngeal and esophageal candidiasis in patients with AIDS. AIDS (London, England), 1995, Volume: 9, Issue:5 Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Candidiasis; Candidiasis, Oral; Child, Preschool; Drug Resistance, Microbial; Esophageal Diseases; Female; Humans; Male; Middle Aged; Triazoles	1995
Activities of D0870, a novel triazole, against Candida lusitaniae and Trichosporon beigelii in experimental murine infections. Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:2 Topics: Animals; Antifungal Agents; Candida; Candidiasis; Male; Mice; Microbial Sensitivity Tests; Mycoses; Triazoles; Trichosporon	1995
Fluconazole, D0870, and flucytosine treatment of disseminated Candida tropicalis infections in mice. Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:4 Topics: Animals; Antifungal Agents; Candidiasis; Drug Therapy, Combination; Fluconazole; Flucytosine; Mice; Mice, Inbred ICR; Triazoles	1995
SCH 51048, a new antifungal triazole active against hematogenous Candida krusei infections in neutropenic mice. Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:3 Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Fluconazole; Immunosuppression Therapy; Kidney; Male; Mice; Mice, Inbred Strains; Neutropenia; Triazoles	1995
Treatment of disseminated Torulopsis glabrata infection with DO870 and amphotericin B. Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:7 Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Drug Synergism; Drug Therapy, Combination; Fluconazole; Immunosuppression Therapy; Kidney; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Spleen; Triazoles	1994
Fever and leukocytosis related to terconazole vaginal suppository. Southern medical journal, 1994, Volume: 87, Issue:7 Topics: Administration, Intravaginal; Adult; Antifungal Agents; Candidiasis; Female; Fever; Humans; Leukocytosis; Suppositories; Triazoles	1994
Optically active antifungal azoles. I. Synthesis and antifungal activity of (2R,3R)-2-(2,4-difluorophenyl)-3-mercapto-1-(1H-1,2,4-triazol-1-yl)-2-b utanol and its stereoisomers. Chemical & pharmaceutical bulletin, 1993, Volume: 41, Issue:6 Topics: Animals; Antifungal Agents; Azoles; Candidiasis; Chromatography, Thin Layer; Fungi; Magnetic Resonance Spectroscopy; Mice; Microbial Sensitivity Tests; Spectrophotometry, Infrared; Stereoisomerism; Structure-Activity Relationship; Triazoles	1993
Optically active antifungal azoles. II. Synthesis and antifungal activity of polysulfide derivatives of (2R,3R)-2-(2,4-difluorophenyl)-3-mercapto-1-(1H- 1,2,4-triazol-1-yl)-2-butanol. Chemical & pharmaceutical bulletin, 1993, Volume: 41, Issue:6 Topics: Animals; Antifungal Agents; Azoles; Candida albicans; Candidiasis; Chromatography, High Pressure Liquid; Magnetic Resonance Spectroscopy; Mice; Oxidation-Reduction; Spectrophotometry, Infrared; Stereoisomerism; Structure-Activity Relationship; Sulfhydryl Compounds; Triazoles	1993
Structure-activity relationships of 3-methyl and 3,3-dimethyl analogs of 2-(2,4-difluorophenyl)-3-(omega-substituted alkyl)sulfonyl-1-(1H-1,2,4-triazol-1-yl)-2-propanols. Chemical & pharmaceutical bulletin, 1996, Volume: 44, Issue:4 Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candida albicans; Candidiasis; Male; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Structure-Activity Relationship; Triazoles	1996
Synthesis and antifungal activity of alkylthio and alkylsulfonyl derivatives of SM-8668. Bioorganic & medicinal chemistry, 1996, Volume: 4, Issue:2 Topics: Alkylation; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Disease Models, Animal; Magnetic Resonance Spectroscopy; Male; Mice; Structure-Activity Relationship; Sulfur; Triazoles	1996
In vitro and in vivo antifungal activities of ER-30346, a novel oral triazole with a broad antifungal spectrum. Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:10 Topics: Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Female; Fluconazole; Fungi; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Thiazoles; Triazoles	1996
Efficacy of ER-30346, a novel oral triazole antifungal agent, in experimental models of aspergillosis, candidiasis, and cryptococcosis. Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:10 Topics: Animals; Antifungal Agents; Aspergillosis; Brain Diseases; Candidiasis; Candidiasis, Oral; Cryptococcosis; Female; Fluconazole; Lung Diseases, Fungal; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Rats; Rats, Sprague-Dawley; Thiazoles; Triazoles	1996
ZD0870 treatment of murine candidiasis caused by fluconazole resistant isolates of Candida albicans. The Journal of antimicrobial chemotherapy, 1996, Volume: 38, Issue:4 Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Fluconazole; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Triazoles	1996
T-8581, a new orally and parenterally active triazole antifungal agent: in vitro and in vivo evaluations. Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:1 Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candida; Candidiasis; Cryptococcus neoformans; Dogs; Fluconazole; Hydroxybutyrates; Itraconazole; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Rabbits; Rats; Triazoles	1997
Variations in DNA subtype and antifungal susceptibility among clinical isolates of Candida tropicalis. Diagnostic microbiology and infectious disease, 1997, Volume: 27, Issue:3 Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; DNA, Fungal; Electrophoresis, Gel, Pulsed-Field; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Mycological Typing Techniques; Polymorphism, Restriction Fragment Length; Triazoles	1997
Efficacy of D0870 treatment of experimental Candida vaginitis. Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:7 Topics: Animals; Antifungal Agents; Candidiasis; Drug Resistance, Microbial; Female; Fluconazole; Mice; Mice, Inbred CBA; Microbial Sensitivity Tests; Triazoles; Vaginitis	1997
Synthesis and antifungal activity of novel thiazole-containing triazole antifungals. Chemical & pharmaceutical bulletin, 1997, Volume: 45, Issue:7 Topics: Animals; Antifungal Agents; Aspergillus fumigatus; Candida; Candidiasis; Mice; Microbial Sensitivity Tests; Saccharomyces cerevisiae; Structure-Activity Relationship; Thiazoles; Triazoles	1997
Activity of SCH 56592 compared with those of fluconazole and itraconazole against Candida spp. Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:10 Topics: Antifungal Agents; Candida; Candidiasis; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Triazoles	1997
In vitro activities of voriconazole (UK-109,496) and four other antifungal agents against 394 clinical isolates of Candida spp. Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:1 Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	1998
Synthesis and antifungal activity of novel thiazole-containing triazole antifungals. II. Optically active ER-30346 and its derivatives. Chemical & pharmaceutical bulletin, 1998, Volume: 46, Issue:4 Topics: Animals; Antifungal Agents; Candidiasis; Culture Media; Fungi; Mice; Microbial Sensitivity Tests; Stereoisomerism; Structure-Activity Relationship; Thiazoles; Triazoles	1998
New azole antifungals. 2. Synthesis and antifungal activity of heterocyclecarboxamide derivatives of 3-amino-2-aryl-1-azolyl-2-butanol. Journal of medicinal chemistry, 1998, May-21, Volume: 41, Issue:11 Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candidiasis; Colony Count, Microbial; Fungi; Male; Mice; Molecular Conformation; Pyrimidinones; Rats; Stereoisomerism; Structure-Activity Relationship; Thiazoles; Thiophenes; Triazoles	1998
New azole antifungals. 3. Synthesis and antifungal activity of 3-substituted-4(3H)-quinazolinones. Journal of medicinal chemistry, 1998, May-21, Volume: 41, Issue:11 Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candidiasis; Colony Count, Microbial; Fungi; Male; Mice; Molecular Conformation; Quinazolines; Rabbits; Rats; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship; Triazoles	1998
In vitro susceptibilities of Candida bloodstream isolates to the new triazole antifungal agents BMS-207147, Sch 56592, and voriconazole. Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:12 Topics: Antifungal Agents; Candida; Candidiasis; Humans; Microbial Sensitivity Tests; Pyrimidines; Thiazoles; Triazoles; Voriconazole	1998
Colorimetric MTT assessment of antifungal activity of D0870 against fluconazole-resistant Candida albicans. Mycoses, 1998, Volume: 41, Issue:11-12 Topics: Antifungal Agents; Candida albicans; Candidiasis; Colorimetry; Drug Resistance, Microbial; Fluconazole; Humans; Microbial Sensitivity Tests; Tetrazolium Salts; Thiazoles; Triazoles	1998
In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents. Journal of clinical microbiology, 1999, Volume: 37, Issue:3 Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole	1999
Systemic candidiasis with candida vasculitis due to Candida kruzei in a patient with acute myeloid leukaemia. Bone marrow transplantation, 1999, Volume: 23, Issue:1 Topics: Acute Disease; Amphotericin B; Antifungal Agents; Candidiasis; Drug Carriers; Humans; Leukemia, Myeloid; Liposomes; Male; Middle Aged; Triazoles; Vasculitis	1999
Antifungal activity of voriconazole (UK-109,496), fluconazole and amphotericin B against hematogenous Candida krusei infection in neutropenic guinea pig model. Journal of chemotherapy (Florence, Italy), 1999, Volume: 11, Issue:1 Topics: Amphotericin B; Animals; Antifungal Agents; Candida; Candidiasis; Disease Models, Animal; Drug Resistance, Microbial; Fluconazole; Guinea Pigs; Male; Neutropenia; Pyrimidines; Random Allocation; Triazoles; Voriconazole	1999
Optically active antifungal azoles. VIII. Synthesis and antifungal activity of 1-[(1R,2R)-2-(2,4-difluoro- and 2-fluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]- 3-(4-substituted phenyl)-2(1H,3H)-imidazolones and 2-imidazolidinones. Chemical & pharmaceutical bulletin, 1999, Volume: 47, Issue:3 Topics: Animals; Antifungal Agents; Aspergillus fumigatus; Candida albicans; Candidiasis; Cryptococcus neoformans; Imidazoles; Magnetic Resonance Spectroscopy; Mice; Microbial Sensitivity Tests; Spectrophotometry, Infrared; Stereoisomerism; Triazoles	1999
International surveillance of blood stream infections due to Candida species in the European SENTRY Program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. SENTRY Participant Group (Europ Diagnostic microbiology and infectious disease, 1999, Volume: 35, Issue:1 Topics: Antifungal Agents; Candida; Candidiasis; Europe; Fungemia; Humans; Microbial Sensitivity Tests; Population Surveillance; Triazoles	1999
SCH 56592. Drugs in R&D, 1999, Volume: 1, Issue:2 Topics: Animals; Antifungal Agents; Candidiasis; Chagas Disease; Drugs, Investigational; Fungi; Humans; Mice; Mycoses; Parasitic Diseases; Triazoles	1999
[Therapy of deep seated mycoses--Timing of administration and selection of antifungal agents]. The Japanese journal of antibiotics, 2000, Volume: 53, Issue:2 Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Mycoses; Nystatin; Pyrimidines; Triazoles; Voriconazole	2000
In vitro and in vivo activities of SCH 56592 (posaconazole), a new triazole antifungal agent, against Aspergillus and Candida. Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:8 Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Disease Models, Animal; Lung Diseases, Fungal; Male; Mice; Microbial Sensitivity Tests; Treatment Outcome; Triazoles	2000
In vitro activity of fluconazole and voriconazole against isolates of Candida albicans from patients with haematological malignancies. The Journal of antimicrobial chemotherapy, 2000, Volume: 46, Issue:3 Topics: Antifungal Agents; Candida albicans; Candidiasis; Fluconazole; Hematologic Neoplasms; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2000
Voriconazole: a new triazole antifungal. The Annals of pharmacotherapy, 2000, Volume: 34, Issue:9 Topics: Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Controlled Clinical Trials as Topic; Drug Interactions; Drug Resistance, Microbial; Humans; Pyrimidines; Retrospective Studies; Tissue Distribution; Triazoles; Voriconazole	2000
Evaluation of the Etest method for determining voriconazole susceptibilities of 312 clinical isolates of Candida species by using three different agar media. Journal of clinical microbiology, 2000, Volume: 38, Issue:10 Topics: Agar; Antifungal Agents; Candida; Candida albicans; Candidiasis; Culture Media; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2000
Susceptibility testing of voriconazole, fluconazole, itraconazole and amphotericin B against yeast isolates in a Turkish University Hospital and effect of time of reading. Diagnostic microbiology and infectious disease, 2000, Volume: 38, Issue:2 Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Hospitals, University; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Reference Standards; Time Factors; Triazoles; Trichosporon; Turkey; Voriconazole	2000
Is there in vivo-in vitro correlation between antifungal susceptibility, species of Candida spp. and clinical outcome? International journal of antimicrobial agents, 2000, Volume: 16, Issue:4 Topics: Antifungal Agents; Candida; Candidiasis; Clinical Trials as Topic; HIV Infections; Humans; Microbial Sensitivity Tests; Neoplasms; Statistics as Topic; Treatment Outcome; Triazoles	2000
Synergism of voriconazole and terbinafine against Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis. Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:3 Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Microbial; Drug Synergism; HIV Infections; Humans; Microbial Sensitivity Tests; Naphthalenes; Pharyngitis; Pyrimidines; Terbinafine; Triazoles; Voriconazole	2001
Fluconazole and voriconazole multidisk testing of Candida species for disk test calibration and MIC estimation. Journal of clinical microbiology, 2001, Volume: 39, Issue:4 Topics: Antifungal Agents; Calibration; Candida; Candidiasis; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2001
[Antifungal susceptibility testing in chronically recurrent vaginal candidosis as basis for effective therapy]. Mycoses, 2000, Volume: 43 Suppl 2 Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Chronic Disease; Ciclopirox; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyridones; Pyrimidines; Terbinafine; Triazoles; Vaginitis; Voriconazole	2000
In vitro and in vivo activities of syn2836, syn2869, syn2903, and syn2921: new series of triazole antifungal agents. Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:9 Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus; Candida albicans; Candidiasis; Disease Models, Animal; Mice; Microbial Sensitivity Tests; Piperazines; Treatment Outcome; Triazoles	2001
International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surv Journal of clinical microbiology, 2001, Volume: 39, Issue:9 Topics: Antifungal Agents; Candida; Candidiasis; Europe; Fluconazole; Fungemia; Humans; Latin America; North America; Pyrimidines; Sentinel Surveillance; Thiazoles; Triazoles; Voriconazole	2001
Evaluation of Etest method for determining posaconazole MICs for 314 clinical isolates of Candida species. Journal of clinical microbiology, 2001, Volume: 39, Issue:11 Topics: Antifungal Agents; Candida; Candidiasis; Humans; Microbial Sensitivity Tests; Triazoles	2001
Voriconazole and fluconazole susceptibility of Candida isolates. Journal of medical microbiology, 2002, Volume: 51, Issue:6 Topics: Antifungal Agents; Candida; Candidiasis; Colony Count, Microbial; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole	2002
In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp. Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:6 Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Pyrimidines; Thiazoles; Triazoles; Voriconazole	2002
In vitro activity of three new triazoles and one echinocandin against Candida bloodstream isolates from cancer patients. The Journal of antimicrobial chemotherapy, 2002, Volume: 50, Issue:1 Topics: Antifungal Agents; Blood; Candida; Candidiasis; Echinocandins; Humans; In Vitro Techniques; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Neoplasms; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole	2002
Comparison of SCH 39304, fluconazole, and ketoconazole for treatment of systemic infections in mice. Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:1 Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Drug Evaluation, Preclinical; Fluconazole; Injections, Intravenous; Ketoconazole; Kidney; Male; Mice; Triazoles	1992
In vitro and in vivo activities of SCH 42427, the active enantiomer of the antifungal agent SCH 39304. Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:2 Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus flavus; Candidiasis; Candidiasis, Vulvovaginal; Cricetinae; Dermatomycoses; Female; Fungi; Guinea Pigs; Male; Mesocricetus; Mice; Microbial Sensitivity Tests; Rats; Rats, Inbred Strains; Stereoisomerism; Triazoles; Trichophyton	1992
Triazole antifungals. V. Synthesis and antifungal activities of some amides related to 3-acylamino-2-aryl-1-triazolyl-2-butanol. Chemical & pharmaceutical bulletin, 1992, Volume: 40, Issue:3 Topics: Animals; Antifungal Agents; Candidiasis; Chlorobenzenes; Mice; Structure-Activity Relationship; Triazoles	1992
Interactions of amphotericin B and SCH 39304 in the treatment of experimental murine candidiasis: lack of antagonism of a polyene-azole combination. Antimicrobial agents and chemotherapy, 1991, Volume: 35, Issue:8 Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Female; Kidney; Mice; Mice, Inbred ICR; Triazoles	1991
Preclinical antimycotic activity of SDZ 89-485: a new orally and topically effective triazole. Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology, 1990, Volume: 28, Issue:6 Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candida albicans; Candidiasis; Candidiasis, Vulvovaginal; Culture Media; Disease Models, Animal; Female; Guinea Pigs; Histoplasmosis; Humans; Mice; Mycoses; Nephritis; Rats; Sporotrichosis; Tinea; Triazoles	1990
Evaluation of Bay R 3783 in rodent models of superficial and systemic candidiasis, meningeal cryptococcosis, and pulmonary aspergillosis. Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:3 Topics: Administration, Oral; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Disease Models, Animal; Drug Administration Schedule; Evaluation Studies as Topic; Female; Fluconazole; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Male; Meningitis; Mice; Pharmaceutical Vehicles; Rats; Rats, Inbred Strains; Triazoles	1990
Candida albicans--do mycelia matter? Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology, 1990, Volume: 28, Issue:3 Topics: Amphotericin B; Animals; Candida albicans; Candidiasis; Culture Media; Kidney Cortex; Kidney Diseases; Kidney Glomerulus; Mice; Triazoles	1990
SCH-39304 in prevention and treatment of disseminated candidiasis in persistently granulocytopenic rabbits. Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:8 Topics: Agranulocytosis; Amphotericin B; Animals; Anti-Bacterial Agents; Antifungal Agents; Candida albicans; Candidiasis; Disease Models, Animal; Female; Fluconazole; Immunosuppression Therapy; Rabbits; Triazoles	1990
Synthesis and antifungal activities of some thiolane-triazole derivatives. Chemical & pharmaceutical bulletin, 1990, Volume: 38, Issue:5 Topics: Animals; Antifungal Agents; Candidiasis; Chemical Phenomena; Chemistry; Fungi; Mice; Microbial Sensitivity Tests; Sulfhydryl Compounds; Triazoles	1990
Oral fluconazole for treatment of disseminated fungal infection. The Pediatric infectious disease journal, 1989, Volume: 8, Issue:1 Topics: Administration, Oral; Candidiasis; Child; Female; Fluconazole; Humans; Triazoles	1989
Treatment of systemic yeast infection with fluconazole. The Journal of antimicrobial chemotherapy, 1989, Volume: 23, Issue:2 Topics: Candidiasis; Fluconazole; Humans; Triazoles	1989
[Clinical evaluation of fluconazole in the case of deep mycosis associated with leukemia]. The Japanese journal of antibiotics, 1989, Volume: 42, Issue:1 Topics: Acute Disease; Adolescent; Adult; Aged; Antifungal Agents; Candidiasis; Drug Evaluation; Drug Tolerance; Female; Fluconazole; Humans; Injections, Intravenous; Leukemia; Lung Diseases, Fungal; Male; Middle Aged; Triazoles	1989
[Clinical evaluation of fluconazole in patients with mycotic infection]. The Japanese journal of antibiotics, 1989, Volume: 42, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus; Candidiasis; Candidiasis, Oral; Drug Evaluation; Female; Fluconazole; Humans; Lung; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Mycoses; Sepsis; Tissue Distribution; Triazoles	1989
[Experience of fluconazole in pediatric patients]. The Japanese journal of antibiotics, 1989, Volume: 42, Issue:1 Topics: Administration, Oral; Adolescent; Antifungal Agents; Candida; Candidiasis; Child; Child, Preschool; Drug Evaluation; Drug Tolerance; Female; Fluconazole; Humans; Infant; Male; Mycoses; Risk Factors; Triazoles	1989
[Clinical efficacy of fluconazole in urinary tract fungal infections]. The Japanese journal of antibiotics, 1989, Volume: 42, Issue:1 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candidiasis; Drug Evaluation; Drug Tolerance; Female; Fluconazole; Humans; Infusions, Intravenous; Male; Middle Aged; Triazoles; Urinary Tract Infections	1989
[Clinical evaluation of fluconazole]. The Japanese journal of antibiotics, 1989, Volume: 42, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Ambulatory Care; Antifungal Agents; Antigens, Fungal; Candidiasis; Child; Cryptococcosis; Cryptococcus neoformans; Drug Evaluation; Esophagitis; Female; Fluconazole; Humans; Male; Meningitis; Middle Aged; Mycoses; Renal Dialysis; Triazoles	1989
[A clinical evaluation of injectable fluconazole in the treatment of deep mycosis associated with hematological malignancy]. The Japanese journal of antibiotics, 1989, Volume: 42, Issue:1 Topics: Acute Disease; Adolescent; Adult; Aged; Antifungal Agents; Candida; Candidiasis; Drug Evaluation; Drug Tolerance; Female; Fluconazole; Humans; Injections, Intravenous; Leukemia; Lymphoma; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Triazoles	1989
[Fluconazole treatment of systemic mycoses]. The Japanese journal of antibiotics, 1989, Volume: 42, Issue:1 Topics: Adolescent; Adult; Aged; Anorexia; Antifungal Agents; Candidiasis; Drug Evaluation; Drug Tolerance; Endophthalmitis; Female; Fluconazole; Humans; Leukopenia; Lung Diseases, Fungal; Male; Middle Aged; Mycoses; Triazoles	1989
[AIDS fungus infections. Fluconazole--a new preparation in development]. Fortschritte der Medizin, 1989, Mar-30, Volume: 107, Issue:10 Topics: Acquired Immunodeficiency Syndrome; Candidiasis; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Humans; Opportunistic Infections; Triazoles	1989
Comparison of the efficacies of amphotericin B, fluconazole, and itraconazole against a systemic Candida albicans infection in normal and neutropenic mice. Antimicrobial agents and chemotherapy, 1989, Volume: 33, Issue:2 Topics: Agranulocytosis; Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Fluconazole; Half-Life; Itraconazole; Ketoconazole; Male; Mice; Neutropenia; Triazoles	1989
Fungal peritonitis complicating continuous ambulatory peritoneal dialysis: successful treatment with fluconazole, a new orally active antifungal agent. The American journal of medicine, 1989, Volume: 86, Issue:6 Pt 2 Topics: Adult; Antifungal Agents; Candidiasis; Dialysis Solutions; Female; Fluconazole; Humans; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Triazoles	1989
New triazole antifungal agents (fluconazole and itraconazole) in the treatment of HIV-related gastrointestinal candidiasis. Scandinavian journal of infectious diseases, 1989, Volume: 21, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Candidiasis; Fluconazole; Gastrointestinal Diseases; Humans; Itraconazole; Ketoconazole; Triazoles	1989
Fluconazole treatment of Candida glabrata peritonitis. The Journal of antimicrobial chemotherapy, 1989, Volume: 24, Issue:1 Topics: Adult; Candida; Candidiasis; Female; Fluconazole; Humans; Peritonitis; Triazoles	1989
Fluconazole (UK-49,858) treatment of candidiasis in normal and diabetic rats. Antimicrobial agents and chemotherapy, 1989, Volume: 33, Issue:7 Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Diabetes Mellitus, Experimental; Fluconazole; Male; Microbial Sensitivity Tests; Rats; Rats, Inbred Strains; Saccharomyces cerevisiae; Triazoles	1989
Treatment of experimental cryptococcal meningitis and disseminated candidiasis with SCH39304. Antimicrobial agents and chemotherapy, 1989, Volume: 33, Issue:10 Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Meningitis; Microbial Sensitivity Tests; Rabbits; Triazoles	1989
Fluconazole in renal candidosis. Lancet (London, England), 1989, Jan-21, Volume: 1, Issue:8630 Topics: Antifungal Agents; Candidiasis; Fluconazole; Humans; Kidney Diseases; Male; Middle Aged; Triazoles	1989
Fluconazole and candidosis. Lancet (London, England), 1989, Feb-11, Volume: 1, Issue:8633 Topics: Adult; Antifungal Agents; Candidiasis; Fluconazole; Heart Transplantation; Humans; Immune Tolerance; Lung Transplantation; Male; Mediastinal Diseases; Triazoles	1989
Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice. Chemotherapy, 1987, Volume: 33, Issue:5 Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy, Combination; Exophiala; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Mice; Mycoses; Triazoles	1987
Activities of fluconazole (UK 49,858) and ketoconazole against ketoconazole-susceptible and -resistant Candida albicans. Antimicrobial agents and chemotherapy, 1988, Volume: 32, Issue:2 Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Microbial; Fluconazole; Ketoconazole; Rabbits; Triazoles	1988
Fluconazole in the management of oropharyngeal candidosis in a predominantly HIV antibody-positive group of patients. Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology, 1988, Volume: 26, Issue:1 Topics: Adult; Aged; Candida albicans; Candidiasis; Candidiasis, Oral; Female; Fluconazole; HIV Seropositivity; Humans; Male; Middle Aged; Pharyngeal Diseases; Time Factors; Triazoles	1988
Fluconazole in the treatment of candidal prosthetic valve endocarditis. BMJ (Clinical research ed.), 1988, Jul-16, Volume: 297, Issue:6642 Topics: Adult; Candidiasis; Endocarditis; Female; Fluconazole; Heart Valve Prosthesis; Humans; Mitral Valve; Triazoles	1988
Use of fluconazole in a patient with documented malabsorption of ketoconazole. Clinical pharmacy, 1988, Volume: 7, Issue:8 Topics: Administration, Oral; Adult; Antifungal Agents; Candidiasis; Candidiasis, Chronic Mucocutaneous; Female; Fluconazole; Humans; Intestinal Absorption; Ketoconazole; Triazoles	1988
Esophageal candidosis in progressive systemic sclerosis: occurrence, significance, and treatment with fluconazole. Scandinavian journal of gastroenterology, 1988, Volume: 23, Issue:10 Topics: Adult; Aged; Antifungal Agents; Candidiasis; Esophageal Diseases; Esophagoscopy; Female; Fluconazole; Humans; Male; Middle Aged; Omeprazole; Ranitidine; Scleroderma, Systemic; Triazoles	1988
Fluconazole resistance in Candida glabrata. Lancet (London, England), 1988, Dec-03, Volume: 2, Issue:8623 Topics: Antifungal Agents; Bile; Candida; Candidiasis; Candidiasis, Vulvovaginal; Drug Resistance, Microbial; Female; Fluconazole; Humans; Middle Aged; Triazoles; Urine	1988
Activity of UK-49,858, a bis-triazole derivative, against experimental infections with Candida albicans and Trichophyton mentagrophytes. Antimicrobial agents and chemotherapy, 1985, Volume: 27, Issue:5 Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Candidiasis, Vulvovaginal; Dermatomycoses; Female; Fluconazole; Guinea Pigs; Immunosuppression Therapy; Ketoconazole; Mice; Rats; Rats, Inbred Strains; Tinea; Triazoles	1985
Efficacy of UK-49,858 (fluconazole) against Candida albicans experimental infections in mice. Antimicrobial agents and chemotherapy, 1985, Volume: 28, Issue:6 Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Female; Fluconazole; Immune Tolerance; Intestinal Diseases; Ketoconazole; Kinetics; Mice; Triazoles	1985
Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and candida pyelonephritis in rabbits. Antimicrobial agents and chemotherapy, 1986, Volume: 29, Issue:4 Topics: Animals; Candidiasis; Cortisone; Cryptococcosis; Dose-Response Relationship, Drug; Fluconazole; Immunity; Itraconazole; Ketoconazole; Meningitis; Pyelonephritis; Rabbits; Triazoles	1986
Azole resistance in Candida albicans. Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology, 1986, Volume: 24, Issue:2 Topics: Adult; Animals; Antifungal Agents; Candida albicans; Candidiasis; Candidiasis, Chronic Mucocutaneous; Disease Models, Animal; Drug Resistance, Microbial; Econazole; Female; Fluconazole; Guinea Pigs; Humans; Imidazoles; Itraconazole; Ketoconazole; Male; Mice; Miconazole; Rats; Rats, Inbred Strains; Triazoles	1986
Penetration of new azole compounds into the eye and efficacy in experimental Candida endophthalmitis. Antimicrobial agents and chemotherapy, 1987, Volume: 31, Issue:1 Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Endophthalmitis; Eye; Fluconazole; Itraconazole; Ketoconazole; Kinetics; Male; Rabbits; Tissue Distribution; Triazoles	1987
New azole compounds: vibunazole (Bay n7133) and Bay L9139, compared with ketoconazole in the therapy of systemic candidosis and in pharmacokinetic studies, in mice. The Journal of antimicrobial chemotherapy, 1985, Volume: 15, Issue:1 Topics: Animals; Antifungal Agents; Candidiasis; Imidazoles; Ketoconazole; Kinetics; Mice; Triazoles	1985